Eye disorder
MONDO:0005328A non-neoplastic or neoplastic disorder that affects the eye. Representative examples include conjunctivitis, glaucoma, cataract, conjunctival squamous cell carcinoma, uveal melanoma, and retinoblastoma.
Also known as: disease of eye, disease of eyeball of camera-type eye, disease or disorder of eyeball of camera-type eye, disorder of eye, disorder of eyeball of camera-type eye, eye disease, eye disorder, eyeball of camera-type eye disease
2608 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
Showing the 400 most recently updated of 732 trials in this tab.
-
New eye drug shows promise for blinding disease
Disease control CompletedThis early-stage trial tests an experimental drug called Kamuvudine-8 (K8) for people with geographic atrophy, a form of advanced age-related macular degeneration that causes vision loss. About 30 participants receive eye injections of K8 and are monitored for 26 weeks to check s…
Phase: PHASE1, PHASE2 • Sponsor: Michelle Abou-Jaoude • Aim: Disease control
Last updated Jul 03, 2026 23:00 UTC
-
New pill aims to slow vision loss in rare usher syndrome
Disease control CompletedThis study tests whether NPI-001 tablets can safely slow or stop vision loss in people with Usher syndrome, a rare genetic condition that causes blindness and hearing loss. About 49 adults will take either the study drug or a placebo for 24 months. The main goal is to see if the …
Phase: PHASE1, PHASE2 • Sponsor: Nacuity Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Could a glaucoma eye drop also heal the cornea?
Disease control CompletedThis study tests whether a combination eye drop (netarsudil/latanoprost) can improve vision and reduce corneal thickness in people with glaucoma and a condition called pseudophakic bullous keratopathy, where the cornea swells after cataract surgery. Half of the 50 participants re…
Phase: PHASE2, PHASE3 • Sponsor: University Hospital Dubrava • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Fish oil for eyes: Omega-3s tested against diabetic retinopathy
Disease control CompletedThis completed trial tested whether daily omega-3 fish oil supplements can help maintain healthy blood vessels in the eyes of adults with type 1 diabetes. 82 participants took either a 1000 mg omega-3 capsule or a placebo for the study, with regular eye exams to monitor retinal c…
Phase: NA • Sponsor: University of Faisalabad • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New eye drug aims to save sight in wet AMD
Disease control CompletedThis trial tests whether an experimental drug called ONS-5010 (a form of bevacizumab) works as well as an approved drug, Lucentis, for treating wet age-related macular degeneration (AMD). Wet AMD causes rapid vision loss due to abnormal blood vessels leaking fluid in the eye. Abo…
Phase: PHASE3 • Sponsor: Outlook Therapeutics, Inc. • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Can a vaccine keep melanoma from coming back? large trial tests immune boosters
Disease control CompletedThis phase 3 trial tested whether a yeast-derived immune stimulant (GM-CSF) and a peptide vaccine, alone or together, could prevent melanoma from returning after surgery. 815 patients with no visible cancer after complete surgical removal of advanced melanoma were randomly assign…
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Tiny implant shows promise for glaucoma control during cataract surgery
Disease control CompletedThis study looked at whether placing a tiny device called iStent during cataract surgery helps lower eye pressure in people with primary open-angle glaucoma. Researchers compared 80 patients who got the implant plus cataract surgery to those who had cataract surgery alone. The go…
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Cheaper eye drug could save sight for millions with diabetes
Disease control CompletedThis study examines how well a biosimilar (a lower-cost copy) of the drug ranibizumab works for diabetic macular edema, a condition that causes vision loss in people with diabetes. Researchers will review medical records of 60 adults who received at least one injection of the bio…
Sponsor: Benha University • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New combo eye injection shows promise for Diabetes-Related vision loss
Disease control CompletedThis study tests an experimental drug called RO7446603, given alone or with existing medications (aflibercept or faricimab), for people with diabetic macular edema—a condition that causes vision loss due to diabetes. The trial has two parts: an early safety phase (Phase I) and a …
Phase: PHASE1, PHASE2 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Promising new eye treatment could halt vision loss from keratoconus
Disease control CompletedThis phase 3 trial tested a new type of corneal cross-linking that does not require removing the surface layer of the eye. It involved 398 people aged 8 to 45 with keratoconus, a condition that thins and bulges the cornea. The treatment uses riboflavin eye drops and ultraviolet l…
Phase: PHASE3 • Sponsor: Epion Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Battle of the lenses: which contact lens best fights childhood nearsightedness?
Disease control CompletedThis trial tests two different contact lenses designed to slow down the progression of myopia (nearsightedness) in children aged 6 to 11. Each child wears one type of lens on each eye for six months, then switches, so researchers can compare how well each lens controls eye growth…
Phase: NA • Sponsor: Essilor International • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Promising new eye treatment could halt vision loss from keratoconus
Disease control CompletedThis phase 3 trial tested a new way to treat keratoconus, a condition where the cornea thins and bulges, causing blurry vision. The treatment uses special eye drops and ultraviolet light to strengthen the cornea without removing its outer layer. 396 people aged 8 to 45 took part …
Phase: PHASE3 • Sponsor: Epion Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New spectacle lens shows promise for sharper vision in myopia
Disease control CompletedThis completed study tested a special lens called HAL for people with nearsightedness (myopia). 88 participants wore either the HAL lens or a standard single vision lens. Researchers measured reading speed and how well they could see at different distances and contrasts. The goal…
Phase: NA • Sponsor: Essilor International • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Could a common arthritis drug tame recurring eye inflammation?
Disease control CompletedThis study tests whether certolizumab pegol (Cimzia), a drug already used for arthritis, can reduce flares of anterior uveitis—a painful eye inflammation—in people with axial spondyloarthritis who have had uveitis before. About 89 adults with active axial spondyloarthritis and a …
Phase: PHASE4 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Eye gel showdown: new cataract surgery gel matches old standard
Disease control CompletedThis study tested a gel called Healon EndoCoat, which is used during cataract surgery to protect the eye and keep it stable. Researchers compared a new version of the gel to the current version in 165 people having cataract surgery in both eyes. The goal was to see if the new gel…
Phase: NA • Sponsor: Johnson & Johnson Surgical Vision, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New glasses aim to stop myopia in its tracks
Disease control CompletedThis study tested two types of advanced glasses—lenslet spectacles and violet filter glasses—against standard single-vision lenses to see if they could slow the worsening of nearsightedness (myopia) in 90 people aged 8 to 20. Participants wore the glasses during all waking hours …
Phase: NA • Sponsor: University of Faisalabad • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New lens implant shows promise for cataract patients
Disease control CompletedThis study tested a new lens called 621 in 105 adults having cataract surgery. The lens was implanted during standard surgery to replace the cloudy natural lens. Researchers checked how well patients could see 6 months after surgery and monitored for any safety issues. The goal w…
Phase: NA • Sponsor: Carl Zeiss Meditec AG • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New eye drops aim to soothe stubborn dry eye
Disease control CompletedThis study tested cyclosporin 0.1% eye drops in 25 adults with moderate to severe dry eye disease that didn't get better with artificial tears. The goal was to see if the drops reduce eye dryness and redness. Participants used the drops alongside their usual tear substitutes for …
Sponsor: Laboratoires Thea • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
23 patients treated: new hope for rare eye infection?
Disease control CompletedThis study looked back at medical records of 23 people in Spain who had a rare eye infection called acanthamoeba keratitis. All patients were treated with polihexanide eye drops as part of a special access program. The main goal was to see how many were cured after treatment, wit…
Sponsor: SIFI SpA • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Higher-Dose eye injection may cut treatment visits for Vein-Related vision loss
Disease control CompletedThis study tested a higher dose (8 mg) of the drug aflibercept against the standard dose (2 mg) in 892 adults with macular edema from a blocked retinal vein. The goal was to see if the higher dose works as well or better while allowing fewer injections. Participants received inje…
Phase: PHASE3 • Sponsor: Bayer • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Lab-grown stem cells may restore damaged eye surfaces
Disease control CompletedThis study tests whether a graft made from a patient's own or donor stem cells can repair the cornea's surface in people with limbal stem cell deficiency, a condition that causes pain, scarring, and vision loss. A small biopsy of limbal tissue is taken from a healthy eye or donor…
Phase: NA • Sponsor: Veerle Van Gerwen • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New hope for vision loss: Long-Term study of pegcetacoplan for dry AMD
Disease control CompletedThis study tested the long-term safety and effectiveness of pegcetacoplan in 792 people with geographic atrophy, a form of advanced dry age-related macular degeneration that causes vision loss. Participants had previously been in earlier pegcetacoplan trials. The goal was to see …
Phase: PHASE3 • Sponsor: Apellis Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New device aims to tackle glaucoma during routine cataract surgery
Disease control CompletedThis completed trial tested the ELIOS System, a device used during cataract surgery to lower eye pressure in adults with mild-to-moderate open-angle glaucoma. The study enrolled 318 participants and measured how many achieved a 20% or greater drop in eye pressure without medicati…
Phase: NA • Sponsor: Elios Vision, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Eye injection shows promise for Diabetes-Related vision loss
Disease control CompletedThis study tests a drug called faricimab (VABYSMO) in people with diabetic macular edema, a condition where diabetes causes fluid buildup in the center of the retina, leading to vision loss. Participants receive injections of faricimab into the eye every four weeks. The goal is t…
Phase: PHASE2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New oral drug shows promise for kids with gaucher disease
Disease control CompletedThis study tested the safety and effectiveness of eliglustat, an oral medication, in 57 children aged 2 to 17 with Gaucher disease types 1 and 3. Some children also received the standard enzyme therapy imiglucerase. Researchers measured how the drug moves through the body, side e…
Phase: PHASE3 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New Laser-Like device aims to ease glaucoma without drops
Disease control CompletedThis study tests a device called the ELIOS System to safely lower eye pressure in adults with mild to moderate open-angle glaucoma. The procedure is done alone, without other surgeries, and aims to reduce pressure by at least 20% while possibly using fewer medications. Researcher…
Phase: NA • Sponsor: Elios Vision, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New eye injection targets two causes of vision loss in wet AMD
Disease control CompletedThis early-phase study tested a new drug called ASKG712 in 56 people with wet age-related macular degeneration (AMD), a leading cause of vision loss. The drug is injected into the eye and works by blocking two proteins that fuel abnormal blood vessel growth. The main goals were t…
Phase: PHASE1, PHASE2 • Sponsor: Visara, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New Dual-Action eye drug shows promise in early trial for Diabetes-Related vision loss
Disease control CompletedThis early study tested a new eye injection called ASKG712 in 10 people with diabetic macular edema, a condition where fluid builds up in the retina and blurs vision. The drug targets two proteins that cause leakage and abnormal blood vessel growth. The main goal was to check saf…
Phase: PHASE1 • Sponsor: Visara, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Gene therapy shows promise for rare Blindness-Causing eye disease
Disease control CompletedThis early-stage study tested a gene therapy called CPK850 in 12 adults with a rare inherited eye disease (RLBP1 retinitis pigmentosa) that causes progressive vision loss and night blindness. The treatment was injected under the retina to deliver a working copy of the faulty gene…
Phase: PHASE1, PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Eye drops could keep Kids' vision from getting worse
Disease control CompletedThis study tested three low doses of atropine eye drops (0.01%, 0.03%, and 0.05%) in 95 children aged 6–18 with nearsightedness. The goal was to see which dose best slowed the worsening of myopia with the fewest side effects. Over 18 months, the 0.05% dose worked best at controll…
Phase: PHASE3 • Sponsor: Khyber Medical College, Peshawar • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Could a daily pill help save sight in diabetic retinopathy?
Disease control CompletedThis study tested an oral medication called APX3330 in 103 adults with moderate to severe diabetic retinopathy, a leading cause of vision loss. The pill aims to reduce inflammation and low-oxygen stress in the eye. Researchers measured whether the drug could improve the severity …
Phase: PHASE2 • Sponsor: Ocuphire Pharma, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Eye muscle surgery showdown: which fix for wandering eyes works best?
Disease control CompletedThis study compared two surgical methods to correct exotropia, a condition where one eye turns outward. In one group, a piece of the inner eye muscle was removed and reattached; in the other, the muscle was folded and shortened. Both groups also had the outer eye muscle loosened.…
Phase: NA • Sponsor: Başakşehir Çam & Sakura City Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New drug faricimab takes on leading cause of blindness in nearsighted people
Disease control CompletedThis study tested a drug called faricimab (VABYSMO®) against an existing treatment (ranibizumab) for people with vision loss caused by abnormal blood vessels growing in the back of the eye due to severe nearsightedness. The trial involved 280 participants who received either fari…
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New eye drops aim to tame pterygium redness
Disease control CompletedThis study tested an eye drop called RMP-A03 in 77 healthy volunteers and people with pterygium, a fleshy growth on the eye. The goal was to see if it safely reduces redness and controls the condition. Participants received either a low dose, high dose, or placebo drops, and rese…
Phase: PHASE2 • Sponsor: Suzhou Raymon Pharmaceuticals Company, Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New hope for thyroid eye disease: drug shows promise in Steroid-Resistant patients
Disease control CompletedThis study looked at whether tocilizumab, a drug that calms the immune system, can help people with active moderate-to-severe thyroid eye disease that did not get better with steroids. Thirty-two adults received the drug every four weeks. Researchers measured improvements in eye …
Sponsor: Medical University of Warsaw • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Gene therapy brings light to rare eye disease in japanese patients
Disease control CompletedThis study tested a gene therapy called voretigene neparvovec in 4 Japanese patients with a rare inherited eye disease that causes vision loss. The treatment was given as an injection under the retina to replace the faulty gene. The goal was to see if it could safely improve ligh…
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New implant aims to tame glaucoma with one dose
Disease control CompletedThis study tested a new implant called PER-001 placed inside the eye to treat open-angle glaucoma. The trial included 33 adults and checked for safety and how well it controlled eye pressure. The implant is designed to release medication over time, potentially reducing the need f…
Phase: PHASE1, PHASE2 • Sponsor: Perfuse Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New eye implant aims to stop vision loss from diabetes
Disease control CompletedThis study tested a new eye implant called PER-001 in 27 people with diabetic retinopathy, a diabetes complication that can damage vision. The implant is placed inside the eye and releases medication over time. The main goal was to check safety and how well people tolerate it, lo…
Phase: PHASE2 • Sponsor: Perfuse Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New lens study shows clearer vision after cataract surgery
Disease control CompletedThis study looked at how well enVista Aspire intraocular lenses work in real-world cataract surgery. 335 adults received the lenses during routine cataract removal. Researchers measured vision sharpness and how satisfied patients and surgeons were with the results.
Phase: NA • Sponsor: Bausch & Lomb Incorporated • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New drug cocktail shows promise for rare eye cancer that spreads to liver
Disease control CompletedThis study tested a combination of two drugs, sitravatinib (a pill) and tislelizumab (an IV infusion), in 16 people with a rare eye cancer (uveal melanoma) that had spread to the liver. The goal was to see if the combo could shrink liver tumors better than current treatments. Par…
Phase: PHASE2 • Sponsor: Grupo Español Multidisciplinar de Melanoma • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New drug shows promise for babies with rare liver disorders
Disease control CompletedThis study tested the safety of a drug called maralixibat in 27 infants under 12 months old with Alagille syndrome or progressive familial intrahepatic cholestasis (PFIC), two rare liver diseases that cause bile buildup. The drug is given as an oral solution and aims to reduce bi…
Phase: PHASE2 • Sponsor: Mirum Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Eye implant showdown: which tiny drain works best for glaucoma?
Disease control CompletedThis study compared two small eye implants, Hydrus and iStent, placed during cataract surgery to help lower eye pressure in people with open-angle glaucoma. 65 patients were followed long-term to see which device worked better and was safer. The goal was to reduce the need for gl…
Phase: NA • Sponsor: Military Institute od Medicine National Research Institute • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Gene therapy trial aims to fix enzyme defect in gaucher disease
Disease control CompletedThis early-stage trial tested a new gene therapy called FLT201 in 10 adults with Gaucher disease type 1. The therapy uses a harmless virus to deliver a working copy of the gene that produces a missing enzyme. The main goal was to check safety and see if the treatment can boost en…
Phase: PHASE1 • Sponsor: Spur Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Can bifocals plus eye drops beat drops alone for Kids' nearsightedness?
Disease control CompletedThis study looked at whether adding bifocal glasses to daily atropine eye drops works better than atropine alone to slow down nearsightedness (myopia) in children. 210 kids aged 4-16 with worsening myopia took part. The main goal was to measure changes in their vision prescriptio…
Phase: NA • Sponsor: University of Faisalabad • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New eye injection shows promise for rare Blindness-Causing gene mutation
Disease control CompletedThis early-stage study tested the safety of a new drug called VP-001, given as an injection into the eye, for people with a rare genetic eye disease (PRPF31 mutation) that causes vision loss. Six participants aged 12 and older received multiple doses. The main goal was to check f…
Phase: PHASE1 • Sponsor: PYC Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New eye injection shows promise for rare Blindness-Causing gene mutation
Disease control CompletedThis early-stage study tested a new drug, VP-001, given as an injection into the eye to see if it is safe for people with a rare genetic eye disease caused by a PRPF31 mutation. Seventeen adults took part. The main goal was to check for side effects, not to measure vision improve…
Phase: PHASE1 • Sponsor: PYC Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New syringe could simplify High-Dose eye treatment
Disease control CompletedThis study tested a pre-filled syringe containing a high dose (8 mg) of the drug aflibercept for two eye conditions: diabetic macular edema and wet age-related macular degeneration. The main goal was to see if retina specialists could prepare and inject the drug easily and safely…
Phase: PHASE3 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
New eye drug PRO-169 takes on lucentis in major trial
Disease control CompletedThis study tested a new eye medication called PRO-169 against a standard drug (ranibizumab) for people with diabetic macular edema, a condition that causes vision loss in people with diabetes. About 509 adults with diabetes took part, receiving injections into the eye over one ye…
Phase: PHASE3 • Sponsor: Laboratorios Sophia S.A de C.V. • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New drug shows promise for Sjögren's syndrome in early trial
Disease control CompletedThis phase 2 trial tested a biologic drug called RC18 in 42 people with primary Sjögren's syndrome, an autoimmune disease that causes dry eyes and mouth. Participants received weekly injections of either RC18 (at 160 mg or 240 mg) or a placebo for 24 weeks. The goal was to see if…
Phase: PHASE2 • Sponsor: RemeGen Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New eye drops aim to speed vision recovery after cornea surgery
Disease control CompletedThis study tested whether ripasudil eye drops can help people with Fuchs endothelial corneal dystrophy recover vision faster after a specific cornea procedure called descemetorhexis. The trial involved 107 adults and compared the drops to a placebo over 12 weeks of treatment, fol…
Phase: PHASE3 • Sponsor: Kowa Research Institute, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Eye drops could replace needles for blinding eye disease?
Disease control CompletedThis early-phase trial tested NT-101 eye drops in 20 people with wet age-related macular degeneration (AMD), a leading cause of vision loss. The study aimed to check safety and see if the drops could reduce fluid buildup and improve vision. Participants received either a low or h…
Phase: PHASE1, PHASE2 • Sponsor: NexThera Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New eye drop aims to tame uveitis inflammation
Disease control CompletedThis phase 3 trial tested TRS01 eye drops in 142 people with active non-infectious anterior uveitis, an inflammatory eye condition that can cause pain and vision loss. Participants used the drops four times a day, and researchers measured how well the drug reduced inflammation co…
Phase: PHASE3 • Sponsor: Tarsier Pharma • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New drug shows promise for Sjögren's syndrome in Mid-Stage trial
Disease control CompletedThis Phase 2 trial tested a drug called CFZ533 (iscalimab) in 273 adults with Sjögren's syndrome, an autoimmune disease causing dryness, pain, and fatigue. Participants received either the drug or a placebo for 24 weeks. The study measured changes in disease activity and symptoms…
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Eye drug safety check for advanced macular degeneration
Disease control CompletedThis study checks the long-term safety of an eye injection called avacincaptad pegol for people with geographic atrophy, a form of advanced age-related macular degeneration that causes vision loss. About 278 adults who finished a previous study of this drug will receive the injec…
Phase: PHASE3 • Sponsor: Astellas Pharma Global Development, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Laser or surgery? new study reveals best option for advanced glaucoma
Disease control CompletedThis study compared two treatments for advanced open-angle glaucoma: a gentle laser (subthreshold diode laser) and a surgical procedure (trabeculotomy). 80 adults with severe glaucoma that was not controlled by maximum medications took part. The goal was to see which treatment be…
Phase: NA • Sponsor: Kafrelsheikh University • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New eye drops show promise for healing corneal damage
Disease control CompletedThis study tested an experimental eye drop called CSB-001 in 131 people with neurotrophic keratitis, a rare condition where the cornea loses sensation and can develop ulcers. Participants used the drops four times daily for 8 weeks. The goal was to see if the drops could fully he…
Phase: PHASE1, PHASE2 • Sponsor: Claris Biotherapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New pill shows promise for rare brain disorders in early trial
Disease control CompletedThis study tested an oral drug called AZ-3102 in 13 people with GM2 gangliosidosis (Tay-Sachs or Sandhoff disease) or Niemann-Pick type C disease. The main goal was to check safety and how the drug moves through the body over 12 weeks. It was a randomized, double-blind, placebo-c…
Phase: PHASE2 • Sponsor: Azafaros B.V. • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New eye drug could save sight for millions with diabetes
Disease control CompletedThis study tested an eye injection called tarcocimab in 255 people with diabetic retinopathy, a diabetes complication that can damage vision. Participants received either the drug or a sham (fake) injection. The goal was to see if the drug improves the severity of the disease and…
Phase: PHASE3 • Sponsor: Kodiak Sciences Inc • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New eye drops aim to replace reading glasses – but are they safe Long-Term?
Disease control CompletedThis phase 3 study tested the long-term safety of LNZ101 eye drops, a combination of aceclidine and brimonidine, in 362 adults aged 45-75 with presbyopia (age-related blurry near vision). Participants used the drops regularly and were monitored for side effects. The study is comp…
Phase: PHASE3 • Sponsor: LENZ Therapeutics, Inc • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New eye injection shows promise for Diabetes-Related vision loss
Disease control CompletedThis phase 2 trial tested a new drug called vamikibart, given as an eye injection, for people with diabetic macular edema—a condition where diabetes causes fluid buildup in the center of the retina, leading to vision loss. The study involved 394 participants and compared vamikiba…
Phase: PHASE2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Simple water trick could prevent eye infections after cataract surgery
Disease control CompletedThis study tested a new way to seal the small cuts made in the eye during cataract surgery. The technique, called posterior flap hydration, uses a special cannula to add fluid to the back of the wound. Researchers checked how tight the seal was right after surgery and looked at t…
Phase: NA • Sponsor: University Hospital Pilsen • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Can light therapy and eye drops stop Kids' myopia from worsening?
Disease control CompletedThis completed study tested whether bright light therapy, special glasses that create myopic defocus, low-dose atropine eye drops, or combinations of these can slow the progression of nearsightedness in schoolchildren. A total of 577 children aged 7-12 with myopia participated. T…
Phase: NA • Sponsor: The Hong Kong Polytechnic University • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New hope for rare eye parasite: study compares drug cocktails and steroid timing
Disease control CompletedThis study looked at the best ways to treat a rare but serious eye infection called acanthamoeba keratitis, which is caused by a parasite. 49 people took part. In the first part, they received either one drug or a combination of two drugs. In the second part, they were given ster…
Phase: PHASE2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Experimental eye injection aims to restore sight in rare blindness conditions
Disease control CompletedThis study tested an experimental drug called KIO-301, given as an injection into the eye, in 32 adults with retinitis pigmentosa or choroideremia—two inherited conditions that cause progressive vision loss. The main goal was to check safety and tolerability at increasing doses. …
Phase: PHASE1, PHASE2 • Sponsor: Kiora Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Eyefill gel devices pass safety check in cataract surgery study
Disease control CompletedThis study tested two gel-like devices, Eyefill SC and Eyefill MB, used during cataract surgery to protect the eye. Researchers followed 148 adults who had cataract surgery with these devices to see if they were safe and worked as intended. The main focus was on changes in the ey…
Phase: NA • Sponsor: Bausch & Lomb GmbH • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Experimental pill targets toxic fat buildup in rare genetic disease
Disease control CompletedThis study tested an oral drug called ADX-629 in 8 people with Sjögren-Larsson syndrome, a rare inherited disorder that causes harmful fatty substances to build up in the skin, brain, and eyes. The main goals were to see if the drug is safe and can reduce these fatty aldehydes. P…
Phase: PHASE1, PHASE2 • Sponsor: University of Nebraska • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Eye drops could replace needles for diabetic eye swelling
Disease control CompletedThis study tested OCS-01, a steroid eye drop, in 552 people with diabetic macular edema (DME), a condition where fluid builds up in the eye and blurs vision. Participants used the drops several times daily for up to a year. The goal was to see if the drops improve vision and redu…
Phase: PHASE2, PHASE3 • Sponsor: Oculis • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Smaller incision, same goal: which glaucoma surgery wins?
Disease control CompletedThis study compared two types of glaucoma surgery—standard trabeculectomy and a smaller 'micro' version—to see which one lowers eye pressure better and causes fewer complications. Researchers followed 100 patients for 3 months after surgery. The goal is to find out if the smaller…
Phase: NA • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Eye drops could replace needles for Diabetes-Related vision loss
Disease control CompletedThis study tested whether a steroid eye drop called OCS 01 can improve vision in people with diabetic macular edema, a common cause of vision loss in diabetes. Over 400 participants used the drops several times daily for a year. The goal was to see if this non-invasive treatment …
Phase: PHASE3 • Sponsor: Oculis • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Direct eye injection shows promise for treating fungal infections
Disease control CompletedThis study tested if injecting the antifungal drug fluconazole directly into the cornea is safe and effective for treating fungal keratitis, a serious eye infection. 40 patients with lab-confirmed fungal infections that were sensitive to fluconazole took part. The researchers mea…
Phase: NA • Sponsor: Tanta University • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
New membrane could speed healing of eye infections
Disease control CompletedThis study tested whether adding a special amniotic membrane containing riboflavin and moxifloxacin to standard PACK-CXL therapy helps heal infected corneal ulcers faster. 32 adults with moderate-to-severe ulcers took part. The goal was to see if the membrane improves corneal hea…
Phase: PHASE2 • Sponsor: Gadjah Mada University • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Vitamin B6 shows promise for diabetes blood vessel health
Disease control CompletedThis study tested whether a form of vitamin B6 called pyridoxamine can improve the health of small blood vessels in people with type 2 diabetes. The researchers gave 40 participants either pyridoxamine or a placebo for a period, then switched treatments to compare effects. They m…
Phase: NA • Sponsor: Maastricht University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Can your own blood or umbilical cord blood ease dry eyes?
Disease control CompletedThis study tested whether eye drops made from a patient's own blood or from donated umbilical cord blood can improve dry eye disease. Eighty adults with dry eye from conditions like Sjogren's syndrome or after using glaucoma drops were randomly assigned to one of the two types of…
Phase: PHASE1, PHASE2 • Sponsor: G.Gennimatas General Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Eye drops could stop a rare cause of blindness
Disease control CompletedThis early-stage study tested whether infliximab, a drug usually given through a vein, can be safely used as eye drops for sterile corneal melt. This condition causes the clear front part of the eye to thin, which can lead to blindness. Seven adults with this condition received t…
Phase: PHASE1 • Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New syringe design makes eye injection easier for doctors
Disease control CompletedThis study tested whether a pre-filled syringe of the medicine SB11 (a biosimilar to ranibizumab) is easy for eye doctors to use. Thirty adults with wet age-related macular degeneration, macular edema from retinal vein occlusion, or myopic choroidal neovascularization received on…
Phase: PHASE2 • Sponsor: Samsung Bioepis Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New eye implant could reduce glaucoma drops
Disease control CompletedThis study tested a small implant called Supraflow v2.2 in 57 adults with open-angle or narrow-angle glaucoma. The implant is placed inside the eye to help drain fluid and lower eye pressure. The goal was to see if it safely reduces pressure and the need for daily eye drops over …
Phase: NA • Sponsor: Ciliatech • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New lens aims to fix cataracts and astigmatism in one surgery
Disease control CompletedThis study tested a new type of artificial lens (PODEYE TORIC) for people having cataract surgery who also have astigmatism, a condition where the eye is shaped like a football instead of a basketball. 261 adults received either the new lens or a standard lens to see if it safely…
Sponsor: Beaver-Visitec International, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Experimental eye drug targets genetic blindness
Disease control CompletedThis phase II trial tested an experimental drug called ADX-2191 in 8 adults with retinitis pigmentosa caused by specific genetic mutations. Participants received monthly injections into one eye for up to six months. The main goal was to check safety, but researchers also looked a…
Phase: PHASE2 • Sponsor: Aldeyra Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New eye drop shows promise for glaucoma patients in large trial
Disease control CompletedThis study tested a new eye drop called Reformulated PG324 to see how well it lowers eye pressure in people with open-angle glaucoma or high eye pressure. About 489 adults took part. The goal was to measure the drop's safety and effectiveness in controlling eye pressure, which is…
Phase: PHASE3 • Sponsor: Alcon Research • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New eye procedure shows promise for kids with glaucoma after cataract surgery
Disease control CompletedThis study tested a minimally invasive surgery called GATT in 30 children who developed glaucoma after cataract surgery. The procedure aims to lower eye pressure by improving fluid drainage inside the eye. Researchers measured changes in eye pressure and the number of glaucoma me…
Phase: NA • Sponsor: Cairo University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Hope for RVCL: experimental drug tested in tiny trial
Disease control CompletedThis phase 2 trial tested the drug crizanlizumab in 18 people with RVCL, a rare and fatal genetic condition that damages small blood vessels in the brain and eyes. There is currently no treatment for RVCL. The study measured changes in brain lesions on MRI scans to see if the dru…
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New drug shows promise in shrinking eye cancer before surgery
Disease control CompletedThis phase 2 trial tested the drug darovasertib in 15 people with high-risk uveal melanoma (a rare eye cancer) who were scheduled for eye removal surgery. Participants took the drug for up to 4 weeks before surgery, and some continued for 6 months afterward. The main goals were t…
Phase: PHASE2 • Sponsor: St Vincent's Hospital, Sydney • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Which glaucoma implant wins? study pits baerveldt against ahmed
Disease control CompletedThis study compared two types of tube shunts (Baerveldt 350 and Ahmed ClearPath 250) in 80 adults with glaucoma that was not controlled by other treatments. The goal was to see which device lowers eye pressure better and is safer. Both implants are used to drain fluid and protect…
Phase: NA • Sponsor: State University of New York at Buffalo • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New eyedrop shows promise for pink eye in small trial
Disease control CompletedThis study tested a new anti-infective eyedrop called SCH1 in 30 adults with acute infectious conjunctivitis (pink eye). Participants received either the active eyedrop or a placebo. The goal was to see if the drug could completely clear redness and discharge. The trial is comple…
Phase: PHASE2 • Sponsor: Sacsh • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New drug aims to slow vision loss in rare eye disease
Disease control CompletedThis study tested an experimental drug called Zimura in 121 people with Stargardt disease, a genetic condition that causes vision loss. Participants received either Zimura injections or a sham procedure. The goal was to see if Zimura could safely slow damage to the retina over 18…
Phase: PHASE2 • Sponsor: Astellas Pharma Global Development, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Gene therapy shows promise for rare eye disease that causes blindness
Disease control CompletedThis Phase 3 trial tested a gene therapy called GS010 in 98 people with Leber hereditary optic neuropathy (LHON), a genetic condition that leads to rapid vision loss. Participants received injections of the therapy or a placebo into both eyes. The study measured changes in vision…
Phase: PHASE3 • Sponsor: GenSight Biologics • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New eye injection shows promise for Diabetes-Related vision loss
Disease control CompletedThis study tested the safety and effectiveness of brolucizumab, a drug injected into the eye, for treating diabetic macular edema (DME) in 66 Indian patients. DME is a complication of diabetes that can cause vision loss. The study aimed to see how well the drug works in real-worl…
Phase: PHASE4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New eye injection shows promise for diabetic retinopathy
Disease control CompletedThis study looked at whether faricimab injections can help people with diabetic retinopathy, a diabetes-related eye disease. Over 12 months, 60 patients received the treatment and doctors measured changes in the back of the eye. The goal was to see if the drug could reduce abnorm…
Sponsor: Federico II University • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Eye drops could replace needles for wet AMD?
Disease control CompletedThis study tested three different doses of SYL1801 eye drops in 99 people with wet age-related macular degeneration (AMD). The goal was to see if the drops are safe and can improve or maintain vision. Participants used the drops for a set period, and their vision was measured aft…
Phase: PHASE2 • Sponsor: Sylentis, S.A. • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New eye drop shows promise for rare corneal disease
Disease control CompletedThis early-stage trial tested an experimental eye drop called STSP-0902 in 82 healthy volunteers to see if it is safe and how the body processes it. The study involved single and multiple doses, with some participants getting a placebo. The goal is to eventually treat neurotrophi…
Phase: PHASE1 • Sponsor: Staidson (Beijing) Biopharmaceuticals Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
One-Time gene injection could end frequent eye shots for wet AMD
Disease control CompletedThis early-stage trial tested a gene therapy called EXG102-031 in 12 people with wet age-related macular degeneration (nAMD), a condition where abnormal blood vessels damage central vision. The therapy was injected into the eye to block these vessels. The main goal was to check s…
Phase: PHASE1 • Sponsor: Exegenesis Bio • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Could arthritis drug humira ease rare skin disease?
Disease control CompletedThis Phase 2 trial tested whether Humira (adalimumab), a drug used for arthritis, can help people with Netherton syndrome, a rare genetic skin condition that causes severe inflammation, itching, and pain. Eleven patients received six injections over three months, followed by thre…
Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Bionic implant shows promise for restoring sight in dry AMD
Disease control CompletedThis study tested a tiny implant called the PRIMA Bionic Vision System in 5 people with advanced dry age-related macular degeneration who had lost central vision. The implant is placed under the retina and uses electrical stimulation to replace damaged light-sensing cells. The go…
Phase: NA • Sponsor: Science Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Supercharged immune cells take on tough melanoma
Disease control CompletedThis early-phase trial tested a new personalized therapy called TBio-4101 for people with advanced melanoma that had stopped responding to standard treatments. The therapy uses a patient's own tumor-fighting immune cells, which are collected, multiplied in the lab, and then infus…
Phase: PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Refillable eye implant could replace monthly shots for diabetic eye disease
Disease control CompletedThis phase 3 trial tested a small, refillable implant placed in the eye that continuously releases the drug ranibizumab to control diabetic retinopathy. The study enrolled 174 people with moderate-to-severe non-proliferative diabetic retinopathy but without swelling in the center…
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Laser breakthrough: new procedure aims to zap away nearsightedness
Disease control CompletedThis completed Phase 1 trial tested the VisuMax femtosecond laser to correct nearsightedness (myopia) in 357 adults aged 22 and older. The procedure removes a small lens-shaped piece of the cornea to reshape the eye and improve vision. Researchers measured how well the treatment …
Phase: PHASE1 • Sponsor: Carl Zeiss Meditec, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New eye drop shows promise for glaucoma without high pressure
Disease control CompletedThis study tested a new eye drop called QLS-111 in 37 people with normal tension glaucoma, a type of glaucoma where eye pressure is not high but vision still gets damaged. The goal was to see if QLS-111 is safe and can lower eye pressure better than a standard drop called timolol…
Phase: PHASE2 • Sponsor: Qlaris Bio, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Fewer eye injections possible? new study tests Higher-Dose aflibercept for DME
Disease control CompletedThis study tested whether a higher dose (8 mg) of the drug aflibercept, given every 16 weeks, works as well as the standard dose (2 mg) given every 8 weeks for Chinese people with diabetic macular edema (DME), a diabetes-related eye condition that causes vision problems. 333 part…
Phase: PHASE3 • Sponsor: Bayer • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Experimental gene injection aims to save sight in rare eye disease
Disease control CompletedThis early-phase trial tested a gene therapy called ZM-01 in 2 boys aged 3 to 18 with X-linked retinoschisis, a rare genetic eye condition that causes vision loss. Each boy received an injection of the therapy into one eye. The main goal was to check safety, but researchers also …
Phase: EARLY_PHASE1 • Sponsor: Zhongmou Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
New 'Micro' eye surgery could ease glaucoma treatment
Disease control CompletedThis study tested a new, less invasive surgery called MIMS for people with glaucoma. The goal was to see if it lowers eye pressure as well as traditional surgery but with fewer side effects. 23 adults with glaucoma took part. The results will help doctors understand if MIMS is a …
Phase: NA • Sponsor: Hôpital Privé de la Baie • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Could fewer injections control wet AMD? new study tests faricimab's staying power
Disease control CompletedThis study looked at 742 people newly diagnosed with wet age-related macular degeneration (nAMD) who received 3 monthly injections of faricimab (Vabysmo) instead of the usual 4. The goal was to see how long the effect lasted before another injection was needed. Researchers tracke…
Sponsor: Rigshospitalet, Denmark • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Safer steroid eye drops for kids? new study tests two options
Disease control CompletedThis study tested two different steroid eye drops—loteprednol and prednisolone—in 66 children with inflammatory nodules in the front part of the eye. The goal was to see if loteprednol could control inflammation as well as prednisolone while causing fewer increases in eye pressur…
Phase: PHASE4 • Sponsor: Fayoum University • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New eye drops aim to restore natural moisture in dry eyes
Disease control CompletedThis study tested whether a new eye drop called AR-15512 can improve the health of the eye surface in people with dry eye disease. 80 participants received either the new drops or artificial tears. The main goal was to see if the drops increased the number of goblet cells, which …
Phase: PHASE3 • Sponsor: Alcon Research • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Can a common cholesterol drug shrink skin lumps in kids with rare liver disease?
Disease control CompletedThis study tested the safety and effectiveness of atorvastatin (Lipitor) in 15 children with Alagille syndrome who had skin cholesterol deposits called xanthomas. The children took the drug for 6 months, and doctors graded the size and number of the lumps. The goal was to see if …
Phase: PHASE4 • Sponsor: Children's Hospital of Fudan University • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Eye drop may prevent eyelash regrowth after trachoma surgery
Disease control CompletedThis study tested whether a steroid eye drop (fluorometholone) given for four weeks after trachoma surgery could stop eyelashes from growing back and rubbing against the eye. Over 2,400 people aged 15 and older took part. The goal was to see if this simple, low-cost addition to s…
Phase: PHASE3 • Sponsor: Massachusetts Eye and Ear Infirmary • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
PanOptix lens safety confirmed years after surgery
Disease control CompletedThis study looked at the long-term safety and performance of AcrySof PanOptix trifocal lenses in 211 people who had them implanted in both eyes 3 to 5 years earlier. Researchers checked vision and recorded any eye problems or device issues. The goal was to make sure these lenses …
Phase: NA • Sponsor: Alcon Research • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New eye drug shows promise for diabetic vision loss
Disease control CompletedThis study tested a drug called faricimab in 179 people with non-proliferative diabetic retinopathy, a condition where diabetes damages blood vessels in the eye. The goal was to see if the drug could improve blood flow in the retina over 48 weeks. Participants received either mon…
Phase: PHASE2 • Sponsor: Greater Houston Retina Research • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Laser plus drops: a new combo for glaucoma?
Disease control CompletedThis study looked at 70 people with mild to moderate glaucoma or high eye pressure. All received a laser treatment called selective laser trabeculoplasty (SLT). Afterward, half used Rocklatan eye drops and half used artificial tears. The goal was to see if Rocklatan lowered eye p…
Sponsor: Colorado Ophthalmology Associates PC • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New lens implant could sharpen vision for kids with cataracts and astigmatism
Disease control CompletedThis study tested a toric intraocular lens implant in 40 children aged 6 to 17 with cataracts and astigmatism (a condition where the eye is shaped like a football). The goal was to see if this special lens could improve vision better than standard surgery. All children had catara…
Phase: NA • Sponsor: Kazakh Eye Research Institute • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New hope for rare eye cancer: IMCgp100 shows promise in advanced uveal melanoma trial
Disease control CompletedThis study tested a new drug called IMCgp100 in 378 adults with a specific genetic type (HLA-A*0201) of advanced uveal melanoma, a rare eye cancer. Participants received either IMCgp100 or one of three standard treatments (dacarbazine, ipilimumab, or pembrolizumab). The main goal…
Phase: PHASE2 • Sponsor: Immunocore Ltd • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New laser procedure shows promise for glaucoma patients
Disease control CompletedThis study from the Mayo Clinic tested a laser procedure called MP-TSCPC in 65 glaucoma patients to see how well it lowers eye pressure. Researchers tracked patients for one year after the procedure, measuring changes in eye pressure, medication use, and vision. The goal was to e…
Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Laser tweak to eye implants could sharpen sight without extra surgery
Disease control CompletedThis study tested a special laser (femtosecond laser) to adjust an artificial lens already placed inside the eye after cataract surgery. The goal was to correct leftover blurriness or astigmatism so people need glasses less. Twelve adults with at least one diopter of remaining re…
Phase: NA • Sponsor: Perfect Lens, LLC • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New eye drug OLN324 tested for wet AMD and diabetic swelling
Disease control CompletedThis early-phase trial tested an investigational eye injection called OLN324 in 164 adults with either wet age-related macular degeneration (AMD) or diabetic macular edema (DME). The main goal was to check safety and how the drug moves in the body, with a preliminary look at whet…
Phase: PHASE1 • Sponsor: Ollin Biosciences, Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Gene therapy offers hope for rare blindness
Disease control CompletedThis Phase 3 trial tests a gene therapy called botaretigene sparoparvovec for X-linked retinitis pigmentosa, a genetic condition that causes progressive vision loss. The study involves 105 participants who receive the therapy via injection under the retina. The main goal is to se…
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Implantable lens offers new hope for nearsightedness
Disease control CompletedThis study tested the safety and effectiveness of the EVO/EVO+ Visian Implantable Collamer Lens (ICL) in 327 adults with moderate to high nearsightedness (with or without astigmatism). The lens is surgically placed inside the eye to correct vision. Researchers tracked side effect…
Phase: NA • Sponsor: Staar Surgical Company • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New spectacle lens aims to halt myopia in teenagers
Disease control CompletedThis completed trial tested whether a specially designed spectacle lens (CARE1.02) can slow the progression of myopia (nearsightedness) in teenagers aged 12 to 17. About 796 teens in Guangzhou, China, wore either the CARE1.02 lens or a standard single-vision lens for one year. Re…
Phase: NA • Sponsor: Zhongshan Ophthalmic Center, Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New combo shows promise for tough lymphomas
Disease control CompletedThis study tested adding lenalidomide to a standard chemotherapy regimen (EPOCH-R) in 55 people with aggressive B-cell lymphomas linked to the MYC gene. The goal was to find the best dose and see if the combination improves how long patients live without their cancer getting wors…
Phase: PHASE1, PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Can a nightly eye drop tame severe nearsightedness in kids?
Disease control CompletedThis study tested three strengths of atropine eye drops (0.01%, 0.04%, and 0.1%) in 219 children with high myopia (severe nearsightedness). The goal was to see which dose best slows the worsening of vision and eye growth over two years. Children received one drop in each eye ever…
Phase: NA • Sponsor: Shanghai Eye Disease Prevention and Treatment Center • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New glasses lens shows promise in slowing kids' nearsightedness
Disease control CompletedThis study tested whether a new type of spectacle lens (partition multi-point defocus lens) is as good as another advanced lens (aspherical lenslets) at slowing the progression of nearsightedness (myopia) in children. 194 children aged 8 to 13 years wore the lenses for two years.…
Phase: NA • Sponsor: Zhongshan Ophthalmic Center, Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Experimental gene therapy aims to slow vision loss from dry AMD
Disease control CompletedThis study tested a gene therapy called JNJ-81201887 in 305 people with geographic atrophy, a late stage of dry age-related macular degeneration that causes blind spots. The treatment is injected into the eye and aims to slow the growth of damaged areas. Researchers measured chan…
Phase: PHASE2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Could a rheumatoid arthritis drug ease Sjogren's symptoms?
Disease control CompletedThis study tested whether baricitinib, a drug already used for rheumatoid arthritis, can help people with active Sjogren's syndrome. 87 participants were randomly assigned to receive either hydroxychloroquine alone or baricitinib plus hydroxychloroquine for 24 weeks. The goal was…
Phase: PHASE2 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Lens implant shows promise for correcting blurry vision
Disease control CompletedThis study looked at how well a special lens implant, called the Visian Toric ICL, works over two years for people with nearsightedness and astigmatism. A total of 125 participants received the implant, which sits behind the iris. The main goal was to see if the lens stays in pla…
Phase: NA • Sponsor: Staar Surgical Company • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New glasses could help Kids' eyes stop getting worse
Disease control CompletedThis study tested special glasses called C.A.R.E. lenses in 100 children aged 6-12 with nearsightedness. The lenses have rings that change how light hits the eye to slow down eye growth. After 12 months, researchers measured changes in eye length and prescription strength to see …
Phase: NA • Sponsor: Benha University • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New drug shows promise for bulging eyes in thyroid disease
Disease control CompletedThis study tested a new medicine called LASN01 in 41 adults with thyroid eye disease, a condition that causes eye bulging and discomfort. The goal was to see if LASN01 could safely reduce eye bulging compared to a placebo. Participants received either LASN01 or a dummy treatment …
Phase: PHASE2 • Sponsor: Lassen Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New combo therapy shows promise for brain metastases
Disease control CompletedThis early study tested combining the immunotherapy drug pembrolizumab with precise radiation (stereotactic radiosurgery) in 25 people with melanoma or lung cancer that had spread to the brain. The main goal was to check for serious side effects. Researchers also tracked how long…
Phase: PHASE1 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Japanese study checks safety of gaucher drug VPRIV in Real-World use
Disease control CompletedThis completed study in Japan looked at the safety and effectiveness of the drug VPRIV (velaglucerase alfa) in 63 people with Gaucher disease. Participants were either new to treatment or switching from another Gaucher therapy. The main goal was to track side effects and serious …
Sponsor: Takeda • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
New vaccine shows promise for rare eye cancer
Disease control CompletedThis early-stage trial tested a personalized vaccine made from a patient's own immune cells and tumor material for people with metastatic uveal melanoma, a rare eye cancer that has spread. The vaccine was added to standard treatments like immunotherapy or chemotherapy. The main g…
Phase: PHASE1 • Sponsor: Hasumi International Research Foundation • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
Targeted pill shows promise for rare genetic cancers
Disease control CompletedThis study tested an experimental drug called ENV-101 (taladegib) in 20 adults with advanced solid tumors that have a specific genetic mutation (PTCH1 loss-of-function). The drug works by blocking a growth pathway in cancer cells. Researchers measured how many patients' tumors sh…
Phase: PHASE2 • Sponsor: Endeavor Biomedicines, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New lens implant study tracks eye pressure spikes
Disease control CompletedThis study looked at how often eye pressure rises after getting an EVO ICL lens implant to correct nearsightedness and astigmatism. Researchers measured pressure in 205 people right after surgery. The goal was to see how many eyes had high pressure, which can be a risk after this…
Phase: NA • Sponsor: Staar Surgical Company • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Eyelid wipes zap Mite-Caused eye inflammation in new study
Disease control CompletedThis study tested whether cleaning the eyelids with wipes containing chlorhexidine can treat blepharitis caused by Demodex mites. 106 adults with the condition used the wipes twice daily for four weeks. Researchers measured mite counts and eyelash debris before and after treatmen…
Phase: PHASE4 • Sponsor: Instituto de Oftalmología Fundación Conde de Valenciana • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Parkinson's drug shows promise for diabetic eye disease
Disease control CompletedThis study tested whether levodopa, a drug used for Parkinson's disease, can help people with diabetes who have early signs of eye damage (diabetic retinopathy). The goal was to find the best dose and understand how it works to improve the retina's electrical signals. 230 adults …
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Special lenses may curb worsening eyesight in children
Disease control CompletedThis study tested whether orthokeratology (OK) lenses, worn overnight, can slow the progression of nearsightedness (myopia) in children aged 8 to 15. The lenses reshape the cornea to change how light focuses on the retina. Researchers measured changes in eye length and retinal fo…
Sponsor: Tianjin Eye Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Gene therapy shows promise in Long-Term study for rare blindness
Disease control CompletedThis study followed 62 people with Leber Hereditary Optic Neuropathy (LHON), a rare inherited eye disease that causes vision loss, for up to 5 years after they received a single gene therapy treatment called GS010. The goal was to see if the treatment remained safe and if any vis…
Phase: PHASE3 • Sponsor: GenSight Biologics • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Gene therapy injection shows promise for rare eye disease
Disease control CompletedThis phase 3 trial tested a single injection of GS010 gene therapy in 39 people with Leber Hereditary Optic Neuropathy (LHON) who had vision loss for 6 months or less. The treatment aims to improve vision by delivering a working copy of the ND4 gene to the eye. Results measured c…
Phase: PHASE3 • Sponsor: GenSight Biologics • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Gene therapy shows promise for rare eye disease causing blindness
Disease control CompletedThis study tested a one-time gene therapy injection, GS010, in 37 adults with Leber Hereditary Optic Neuropathy (LHON), a genetic condition that causes rapid vision loss. Participants had vision loss for 6 to 12 months before treatment. The goal was to see if the therapy could im…
Phase: PHASE3 • Sponsor: GenSight Biologics • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Gene therapy for inherited blindness passes early safety check
Disease control CompletedThis study tested a gene therapy called GS010 in 19 adults with Leber Hereditary Optic Neuropathy (LHON), a rare inherited eye disease that causes rapid vision loss. The main goal was to see if the treatment is safe and tolerable at different doses. The therapy uses a harmless vi…
Phase: PHASE1, PHASE2 • Sponsor: GenSight Biologics • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New gel stent shows promise for glaucoma patients
Disease control CompletedThis study tested a gel stent implant for open-angle glaucoma, a leading cause of blindness. 74 adults aged 45+ received the implant and were followed for 12 months. The goal was to safely lower eye pressure and reduce the need for glaucoma medications.
Phase: PHASE3 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Could a diabetes drug ease pressure in the brain?
Disease control CompletedThis completed phase 4 trial tested whether a rapid weight loss program using semaglutide (Ozempic/Wegovy) plus a very low calorie diet can help people with idiopathic intracranial hypertension (IIH), a condition where high pressure in the skull causes headaches and vision proble…
Phase: PHASE4 • Sponsor: Rigmor Højland Jensen • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New air bubble technique may help treat thin corneas in keratoconus
Disease control CompletedThis study tested a modified version of corneal collagen cross-linking, a procedure to strengthen the cornea, in 39 people with keratoconus who had thin corneas. Before the standard treatment, doctors added a small air bubble into the cornea to protect the inner layer. The goal w…
Phase: NA • Sponsor: Cairo University • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Blood-Based injection shows promise for slowing dry AMD
Disease control CompletedThis study tested whether injecting a concentrated form of a patient's own blood, called platelet-rich plasma (PRP), into the eye could slow the progression of advanced dry age-related macular degeneration (AMD). Fourteen people with advanced dry AMD received three PRP injections…
Phase: NA • Sponsor: Marmara University Pendik Training and Research Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
New stitch technique may improve glaucoma surgery outcomes
Disease control CompletedThis study tested a modified surgical technique for open-angle glaucoma, adding a tiny mattress stitch to the standard deep sclerectomy procedure. 26 adults with glaucoma that was not controlled by eye drops were randomly assigned to receive either the standard or modified surger…
Phase: NA • Sponsor: Beni-Suef University • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Early eye surgery may prevent retinal detachment after bleeding
Disease control CompletedThis study looked at whether early surgery (vitrectomy) or waiting with ultrasound monitoring is better for people with sudden, dense bleeding inside the eye. The goal was to see if early surgery could lower the chance of the retina detaching. Only 8 adults with recent bleeding f…
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Sjögren's drug shows promise in safety extension trial
Disease control CompletedThis study looked at the long-term safety of efgartigimod in 24 adults with primary Sjögren's syndrome who had already completed a prior trial. Efgartigimod works by lowering certain antibodies that may drive the disease. The main goal was to track side effects over 48 weeks, wit…
Phase: PHASE2 • Sponsor: argenx • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Modular eye lens shows promise for clearer sight at all distances
Disease control CompletedThis study tested a new modular lens called the AVL200, implanted during cataract surgery to also correct presbyopia (age-related blurry near vision). Nine people received the lens and were followed for one year. Researchers measured how well they could see at different distances…
Phase: NA • Sponsor: Atia Vision • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New eye injection shows promise for restoring sight after stroke in the eye
Disease control CompletedThis study tested an experimental drug called KUS121, given as an eye injection, for people who suddenly lost vision due to a blocked artery in the eye (central retinal artery occlusion). The goal was to see if the injection could improve vision better than a sham procedure. The …
Phase: PHASE2 • Sponsor: Kyoto Drug Discovery and Development Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Can a liver cancer drug stop eye cancer spread?
Disease control CompletedThis study tested the drug sorafenib (Nexavar) in 32 adults with uveal melanoma that had spread to other parts of the body. The goal was to see if the drug could stop tumors from growing for at least 24 weeks. Sorafenib is already used for other cancers, and researchers wanted to…
Phase: PHASE2 • Sponsor: University Hospital, Caen • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New combo therapy shows promise for rare eye cancer
Disease control CompletedThis study tested whether a combination of two drugs, nivolumab and relatlimab, can shrink tumors in people with metastatic uveal melanoma, a rare eye cancer that has spread. Twenty-seven participants received the treatment to see how many responded. The goal was to control the d…
Phase: PHASE2 • Sponsor: Jose Lutzky, MD • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New gel keeps eyes safe during cataract surgery, study finds
Disease control CompletedThis study tested OpHLINE, a clear gel used during cataract surgery to keep the eye stable and protect delicate cells. Researchers followed 69 adults who had cataract surgery with the gel. The gel worked well in most cases, and serious complications were rare. The results support…
Phase: NA • Sponsor: i+Med S.Coop. • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Steroid showdown: oral vs. injected for rare eye disease
Disease control CompletedThis study looked at 30 people with Vogt-Koyanagi-Harada (VKH) disease, a rare autoimmune condition that causes eye inflammation and can lead to vision loss. Researchers compared two initial treatments: oral prednisolone (steroid pills) and steroid injections near the eye. They c…
Sponsor: Benha University • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New combo therapy may slow severe nearsightedness in kids
Disease control CompletedThis study tested whether combining low-dose atropine eye drops with special soft contact lenses can slow the progression of high myopia (severe nearsightedness) in children aged 6-12. 120 children were split into three groups: one got the combo therapy, one got atropine alone wi…
Phase: PHASE4 • Sponsor: Beijing Tongren Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
One laser session may be as safe as four for diabetic eyes
Disease control CompletedThis study looked at 83 people with diabetes and early-stage eye disease. It compared having laser treatment in one session versus four sessions to see which approach better controls the disease and reduces the risk of swelling in the center of the eye. The main goal was to measu…
Phase: PHASE3 • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Faricimab shows promise for Long-Term control of diabetic eye disease
Disease control CompletedThis study looked at the long-term safety of faricimab, a medicine injected into the eye, for people with diabetic macular edema (DME). About 1,500 patients who had completed earlier studies received faricimab at personalized intervals. The main goal was to track side effects, no…
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Could a smartphone camera spot blinding eye diseases?
Diagnosis CompletedThis study tests whether a smartphone-based camera can accurately screen for eye diseases such as diabetic retinopathy, glaucoma, and age-related macular degeneration. About 550 patients will have photos taken with both the smartphone camera and standard equipment. Ophthalmologis…
Sponsor: University of Michigan • Aim: Diagnosis
Last updated Jul 01, 2026 00:00 UTC
-
New DNA test could revolutionize diagnosis of eye infections
Diagnosis CompletedThis study tested a new method called metagenomic deep sequencing (MDS) to find the cause of eye infections. 100 adults with suspected infectious uveitis or endophthalmitis were randomly assigned to have their doctors receive MDS results or not, in addition to standard tests. The…
Phase: NA • Sponsor: University of California, San Francisco • Aim: Diagnosis
Last updated Jun 28, 2026 00:00 UTC
-
AI eye scanner could catch glaucoma before it steals your sight
Diagnosis CompletedThis study tested an AI tool called VeriSee GLC that analyzes color images of the back of the eye to find signs of glaucoma. Researchers looked at 773 adults' existing eye images to see how well the AI could identify people who might have glaucoma, comparing its results to a pane…
Sponsor: Acer Medical Inc. • Aim: Diagnosis
Last updated Jun 27, 2026 14:03 UTC
-
Can a camera replace the slit lamp for Post-Surgery eye checks?
Diagnosis CompletedThis trial compares a telemedical device called Occyo One to the standard slit lamp exam for detecting complications after cataract surgery. About 365 patients scheduled for cataract surgery will have their eyes imaged with Occyo One before and after surgery. A remote ophthalmolo…
Phase: NA • Sponsor: Medical University Innsbruck • Aim: Diagnosis
Last updated Jun 27, 2026 14:02 UTC
-
AI assistant boosts eye doctor accuracy in retinal disease diagnosis?
Diagnosis CompletedThis study tested whether an AI tool can help eye doctors diagnose four common retinal diseases (diabetic retinopathy, age-related macular degeneration, retinal vein occlusion, and glaucoma) more accurately and quickly. Ten doctors from five hospitals read fundus images both with…
Phase: NA • Sponsor: Inje University • Aim: Diagnosis
Last updated Jun 27, 2026 14:01 UTC
-
New eye scan may spot glaucoma before vision loss begins
Diagnosis CompletedThis study tested whether a high-resolution eye scan called SD-OCT can diagnose glaucoma more accurately than standard methods. Researchers compared 109 people with and without glaucoma using the scan. The goal was to see if this technology could catch the disease earlier, before…
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Diagnosis
Last updated Jun 27, 2026 13:00 UTC
-
New imaging tool may help detect Eye-Area skin cancer without a biopsy
Diagnosis CompletedThis study tested a non-invasive imaging device called dermal optical coherence tomography (D-OCT) to diagnose basal cell carcinoma (a common skin cancer) around the eye area. Researchers compared its accuracy to standard biopsy results in 210 adults with suspected lesions. The g…
Sponsor: Vejle Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 12:37 UTC
-
Eye scans may reveal hidden heart risks
Diagnosis CompletedThis study looked at whether a special eye scan (SS-OCTA) can detect signs of cardiovascular disease. Researchers compared retinal blood vessel changes to results from a standard carotid ultrasound in 42 adults. The goal was to see if the eye scan could predict the presence or se…
Sponsor: Northwestern University • Aim: Diagnosis
Last updated Jun 27, 2026 12:37 UTC
-
New eye exam gadgets could replace dilation drops for kids
Diagnosis CompletedThis study tested two new devices that automatically measure vision in children aged 6 to 16. The devices use special lenses that adjust themselves, avoiding the need for eye drops that dilate the pupils. Researchers compared the results from 43 children to the standard dilation …
Sponsor: University Hospital, Brest • Aim: Diagnosis
Last updated Jun 27, 2026 12:36 UTC
-
AI reads biopsies to spot Sjogren's syndrome
Diagnosis CompletedThis study tested an artificial intelligence (AI) algorithm designed to analyze images of minor salivary gland biopsies to help diagnose Sjogren's syndrome. Researchers used 1,000 biopsy samples from patients with suspected Sjogren's to see if the AI could accurately count immune…
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Diagnosis
Last updated Jun 27, 2026 12:26 UTC
-
Which glaucoma vision test is best? new study puts three to the test
Diagnosis CompletedThis study compared three different devices that measure side vision in people with glaucoma. Fifty-four adults each took all three tests in one visit. Researchers timed how long each test took and checked how well the results matched. The goal is to find which test is fastest an…
Phase: PHASE4 • Sponsor: Gainesville Eye Associates • Aim: Diagnosis
Last updated Jun 27, 2026 12:26 UTC
-
New eye pressure checker matches gold standard in small study
Diagnosis CompletedThis completed pilot study tested whether the Nidek TONOREF III, a device that measures eye pressure and other eye features, gives results similar to the standard Goldmann tonometer. Fifty-two adults had their eye pressure measured with both devices to check for agreement. The go…
Sponsor: Nidek Co. LTD. • Aim: Diagnosis
Last updated Jun 27, 2026 12:23 UTC
-
New eye pressure gadget put to the test
Diagnosis CompletedThis study checked if a new device called the iCare IC1000 can accurately measure pressure inside the eye. Researchers compared it to standard tonometers in 168 adults. The goal was to see if the IC1000 meets official accuracy standards for use in clinics.
Phase: NA • Sponsor: Icare Finland Oy • Aim: Diagnosis
Last updated Jun 27, 2026 12:04 UTC
-
Smart contact lens could revolutionize glaucoma monitoring
Diagnosis CompletedThis study tested a new smart contact lens called miLens that records eye pressure patterns over 24 hours in 86 adults with glaucoma and healthy volunteers. Participants wore the lens in one eye and took smartphone readings every 15 minutes while awake. Researchers compared the l…
Sponsor: Smartlens, Inc. • Aim: Diagnosis
Last updated Jun 27, 2026 12:01 UTC
-
AI eye doctor: new tool aims to spot rare retinal diseases
Diagnosis CompletedThis study tested an artificial intelligence (AI) system called Retina4IRD that helps doctors diagnose inherited retinal diseases, which are rare eye conditions that can cause vision loss. The AI looks at eye images and patient information to suggest which gene might be causing t…
Phase: NA • Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Diagnosis
Last updated Jun 27, 2026 11:01 UTC
-
AI eye check could catch blood pressure damage early
Diagnosis CompletedThis study tested an artificial intelligence tool called RetinAIcheck to see if it can accurately detect and grade hypertensive retinopathy—eye damage caused by high blood pressure. Researchers used 729 patients' eye photos and compared the AI's results to assessments by eye doct…
Sponsor: I.M. Sechenov First Moscow State Medical University • Aim: Diagnosis
Last updated Jun 27, 2026 11:01 UTC
-
New AI eye screening tool could help millions with diabetes avoid blindness
Diagnosis CompletedThis study tested a software called OPTDR01 that automatically checks retinal images for signs of diabetic retinopathy, a leading cause of vision loss. Researchers enrolled 300 adults with diabetes to see if the tool is easy to use and practical in a clinic setting. The goal is t…
Sponsor: Optain Health • Aim: Diagnosis
Last updated Jun 27, 2026 09:08 UTC
-
New eye camera tested for glaucoma detection
Diagnosis CompletedThis study tested a new imaging device called the P200TE on 53 people with glaucoma. The goal was simply to see how well it could capture images of the back of the eye. It was not a treatment study, so there were no health benefits or risks for participants.
Phase: NA • Sponsor: Optos, PLC • Aim: Diagnosis
Last updated Jun 27, 2026 09:04 UTC
-
New screen mode may keep your eyes fresh longer
Prevention CompletedThis study tested whether a new dynamic color temperature mode on screens can prevent dry eye and visual fatigue. Thirty adults read text on a screen for 50 minutes under different color settings. Researchers measured eye fatigue and dryness before and after to see if the new mod…
Phase: NA • Sponsor: Beijing Tongren Hospital • Aim: Prevention
Last updated Jun 27, 2026 13:06 UTC
-
Cataract surgery pain relief: which additive works best?
Symptom relief CompletedThis study tested whether adding dexmedetomidine or dexamethasone to a local anesthetic mixture improves pain control and patient satisfaction during cataract surgery. 75 adults undergoing eye surgery received one of the two additives or a placebo. The main goal was to see how lo…
Phase: NA • Sponsor: Helwan University • Aim: Symptom relief
Last updated Jun 28, 2026 00:00 UTC
-
New eye drops aim to soothe dry eye sufferers
Symptom relief CompletedThis Phase 3 trial tested rebamipide eye drops in 762 people with dry eye lasting at least 6 months. Participants received either rebamipide or placebo drops for 26 weeks. The goal was to see if the drops could reduce eye surface damage and discomfort better than placebo.
Phase: PHASE3 • Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 14:03 UTC
-
Eye insert could ease allergy symptoms for contact lens wearers
Symptom relief CompletedThis early study tested a dexamethasone eye insert placed by a doctor against a standard steroid gel for treating allergy and dry eye symptoms in 36 people with keratoconus who wear gas permeable contact lenses. The goal was to see if the insert improves signs like eyelid bumps a…
Phase: EARLY_PHASE1 • Sponsor: Illinois College of Optometry • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
Green tea cream shows promise for rare 'Fish Scale' skin disease
Symptom relief CompletedThis study tested a cream made from green tea extract (Veregen) on 6 people with lamellar ichthyosis, a rare genetic condition that causes severe dry, scaly skin. Participants applied the cream to one side of their body and a standard moisturizer to the other for 4 weeks. The goa…
Phase: PHASE3 • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Anti-aging pill may soothe screen-weary eyes, early study hints
Symptom relief CompletedThis completed study tested whether taking anti-aging compound capsules twice daily for four weeks could reduce eye fatigue and discomfort in 25 healthy adults aged 20 to 60. The capsules contained a mix of botanical extracts, omega-3s, vitamins, and minerals. Researchers measure…
Phase: NA • Sponsor: China Medical University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Eye drops bring relief to dry eye sufferers
Symptom relief CompletedThis study tested whether using Systane PRO eye drops consistently for 30 days can relieve symptoms of dry eye disease and improve daily functioning. Thirty-three adults with mild to moderate dry eye took part. The main goal was to see if their eye comfort scores improved from th…
Phase: PHASE4 • Sponsor: Gordon Schanzlin New Vision • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Could a daily drink help tired eyes? small trial tests lutein formula for nearsightedness
Symptom relief CompletedThis completed early-phase study tested a daily drink called Baby Drink, which contains lutein, blueberry extract, vitamins, and minerals, in 20 adults with mild myopia (nearsightedness less than 700 degrees). Participants took one 20 ml pack per day for one month. Researchers tr…
Phase: EARLY_PHASE1 • Sponsor: China Medical University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
New lens implant study aims for sharper sight after cataract surgery
Symptom relief CompletedThis study looked at 43 cataract surgery patients to see if a special lens (low cylinder toric IOL) improves vision more than a standard lens. The goal was to find out if the toric lens leads to better eyesight without glasses. Results focus on distance vision and how much astigm…
Phase: NA • Sponsor: Ifocus Oyeklinikk • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
New eye drops aim to soothe dry eye sufferers
Symptom relief CompletedThis Phase 3 trial tested rebamipide eye drops in 755 people with dry eye for at least 6 months. Participants received either rebamipide or placebo drops for up to 52 weeks. The goal was to see if the drops could reduce eye surface damage and ease discomfort.
Phase: PHASE3 • Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
New eye drop aims to soothe dry, irritated eyes
Symptom relief CompletedThis study tests an experimental eye drop called GRF312 5% in 100 adults with dry eye disease. The goal is to see if it is safe and helps relieve symptoms. Participants will use the drops at home and attend clinic visits for check-ups.
Phase: PHASE2 • Sponsor: Instituto Grifols, S.A. • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Could a simple nerve stimulator ease chronic eye pain?
Symptom relief CompletedThis pilot study tested whether a TENS device, placed on the forehead, is safe and practical for treating chronic eye pain in 39 veterans. Participants used the device at home for 6 months. The goal was to see if it reduces pain and to prepare for a larger trial.
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
New eye drops aim to soothe dry eyes – first human test underway
Symptom relief CompletedThis early study tests whether RCI001 eye drops are safe and tolerable in 40 healthy adult men. Participants receive either the active eye drops or a placebo, and researchers monitor for side effects and how the drug behaves in the body. This is a first step toward possibly devel…
Phase: PHASE1 • Sponsor: Rudacure • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
New eye drops aim to soothe dry eye in bone marrow transplant patients
Symptom relief CompletedThis study tested whether CAM-101 eye drops are safe and can help relieve dry eye in people who developed the condition after a bone marrow transplant (graft-versus-host disease). 64 adults received either a low or high dose of CAM-101 or a placebo drop four times a day for six w…
Phase: PHASE1, PHASE2 • Sponsor: Cambium Bio Limited • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
Eye injection may ease pain of laser surgery for diabetic patients
Symptom relief CompletedThis study compared two ways to control pain during laser treatment for diabetic retinopathy: a numbing injection around the eye versus standard numbing eye drops. Fifty adults with diabetes were split into two groups to receive either the injection or a sham injection with drops…
Phase: PHASE4 • Sponsor: Asociación para Evitar la Ceguera en México • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
New lens prescription method aims to sharpen your sight
Symptom relief CompletedThis study tested whether glasses made with a new prescription method (Essilor AVA) give better vision and comfort than standard glasses. About 120 adults with common vision problems wore both types of lenses for two weeks each. The goal was to see which people preferred and if t…
Phase: NA • Sponsor: Essilor International • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC
-
No-Needle eye pressure check: new tips could replace numbing drops
Symptom relief CompletedThis study tested four new types of tonometer tips that can measure eye pressure without numbing drops. 49 adults getting routine eye exams tried the new tips and rated them for comfort. The goal is to find the best design for a home-use device that makes glaucoma monitoring easi…
Phase: NA • Sponsor: Duke University • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC
-
Supplement shows promise for dry eye sufferers in new study
Symptom relief CompletedThis study tested whether a dietary supplement called Nutritears, containing lutein, zeaxanthin, curcuminoids, and vitamin D3, can improve dry eye symptoms. 131 adults with dry eye syndrome took either the supplement or a placebo daily for 8 weeks. Researchers measured tear produ…
Phase: NA • Sponsor: Applied Science & Performance Institute • Aim: Symptom relief
Last updated Jun 27, 2026 13:03 UTC
-
Which multifocal contact lens is best? new study puts two to the test
Symptom relief CompletedThis completed pilot study tested two different daily disposable multifocal contact lenses in 74 adults aged 40 to 70 with presbyopia. Participants wore each lens type for about a week, and researchers measured how well they could see at distance, intermediate, and near distances…
Phase: NA • Sponsor: Johnson & Johnson Vision Care, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 13:03 UTC
-
New contact lens trial offers hope for astigmatism sufferers
Symptom relief CompletedThis study tested how well people with astigmatism who had never worn contact lenses liked a new type of soft lens that is replaced every week. Forty adults wore the lenses for about three weeks and reported on their vision and comfort. The goal was to see if these lenses could b…
Phase: NA • Sponsor: Ohio State University • Aim: Symptom relief
Last updated Jun 27, 2026 13:03 UTC
-
Warm eyelid treatment for dry eye gets a boost?
Symptom relief CompletedThis study tested the TearCare MGX system, a device that applies heat to the eyelids, for treating dry eye caused by meibomian gland dysfunction. 21 adults with dry eye symptoms received the treatment, comparing a standard version with one that includes an extended warming hold. …
Phase: NA • Sponsor: Sight Sciences, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 13:02 UTC
-
Which contact lens feels better? study puts two brands to the test
Symptom relief CompletedThis study tested two types of daily disposable contact lenses for people with astigmatism to see which one felt more comfortable. 134 adults wore each lens for one week and rated their comfort. The goal was to find out which lens provided longer-lasting comfort and a better over…
Phase: NA • Sponsor: Johnson & Johnson Vision Care, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 13:02 UTC
-
New contact lenses for astigmatism put to the test
Symptom relief CompletedThis study tested a new type of daily disposable contact lens for people with astigmatism. 281 contact lens wearers tried the lenses to see how well they corrected vision, stayed in place, and felt comfortable. The goal was to make sure the new lenses are safe and work well for e…
Phase: NA • Sponsor: Johnson & Johnson Vision Care, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 13:02 UTC
-
USB-Powered eye mask beats disposable pads for dry eyes
Symptom relief CompletedThis study tested two ways to warm the eyelids for people with dry eyes caused by meibomian gland dysfunction. Fifteen adults used a USB-powered warm compress and a self-heating eye mask for two weeks each. Both devices improved tear stability and comfort, but the USB-powered ver…
Phase: NA • Sponsor: King Saud University • Aim: Symptom relief
Last updated Jun 27, 2026 13:01 UTC
-
New lens implant aims to sharpen vision at all distances
Symptom relief CompletedThis study tested a newer trifocal lens implant (Clareon PanOptix Pro) against an older one (Clareon PanOptix) in 71 adults having cataract surgery in both eyes. Each person got one of each lens, so their eyes could be compared directly. The goal was to see if the newer lens prov…
Phase: NA • Sponsor: Alcon Research • Aim: Symptom relief
Last updated Jun 27, 2026 13:01 UTC
-
Tiny corneal lens holds up after 4 years for near vision
Symptom relief CompletedThis study checked the safety and effectiveness of the CorVision microlens, a tiny implant placed in the cornea to help with presbyopia (age-related difficulty seeing up close). About 95 people who had the implant in an earlier study came back for a single 4-year follow-up visit.…
Sponsor: Gemini Eye Clinic • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Eye redness drops show promise in large trial
Symptom relief CompletedThis completed Phase 3 trial tested a new eye drop containing brimonidine and sodium hyaluronate against Lumify for reducing eye redness in 578 adults. Participants used the drops four times daily, and redness was measured over several hours. The goal was to see if the new drop w…
Phase: PHASE3 • Sponsor: Bausch & Lomb Incorporated • Aim: Symptom relief
Last updated Jun 27, 2026 12:39 UTC
-
Saline showdown: which eye drop clears Post-Surgery swelling faster?
Symptom relief CompletedThis study tested whether a stronger (5%) or weaker (3%) saltwater eye drop works better to reduce corneal swelling after cataract surgery. 70 adults who developed swelling after surgery received one of the two treatments. The main goal was to see which drop thinned the cornea mo…
Phase: NA • Sponsor: Muhammad Aamir Latif • Aim: Symptom relief
Last updated Jun 27, 2026 12:37 UTC
-
Sugar solution tested for safer eye surgery
Symptom relief CompletedThis study tested whether giving mannitol (a sugar solution) through a vein before cataract surgery improves eye pressure and the depth of the front chamber of the eye. Sixty adults aged 30-80 who were having cataract surgery took part. Half received mannitol and half received a …
Phase: NA • Sponsor: Muhammad Aamir Latif • Aim: Symptom relief
Last updated Jun 27, 2026 12:37 UTC
-
New ointment shows promise for rare skin scaling disease
Symptom relief CompletedThis study tested two strengths of a topical isotretinoin ointment (TMB-001) in 34 people aged 9 and older with congenital ichthyosis, a rare genetic skin condition causing severe scaling. The main goal was to see if the ointment could reduce scaling by at least 50% compared to a…
Phase: PHASE2 • Sponsor: LEO Pharma • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC
-
Which eye drop stings less? small study pits flarex against lotemax SM
Symptom relief CompletedThis study tested how comfortable two prescription steroid eye drops feel right after use. Forty adults with eye inflammation or dry eye received one drop of Flarex in one eye and one drop of Lotemax SM in the other. They rated comfort and vision impact at 30 seconds, 5 minutes, …
Phase: PHASE4 • Sponsor: Harrow Inc • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
Warm compress device shows promise for dry eyes before cataract surgery
Symptom relief CompletedThis study tested whether using the Systane iLux device—which applies heat and pressure to the eyelids—before cataract surgery could improve dry eye symptoms. Thirty adults scheduled for cataract surgery received the treatment in one eye. Researchers measured changes in tear film…
Phase: NA • Sponsor: George Washington University • Aim: Symptom relief
Last updated Jun 27, 2026 12:33 UTC
-
New eye drops could replace reading glasses for millions
Symptom relief CompletedThis study tested an eye drop called LNZ101 to help people with presbyopia (age-related trouble seeing up close) read without glasses. 469 adults aged 45-75 received the drops, and researchers measured how many gained clear near vision without losing distance vision on the first …
Phase: PHASE3 • Sponsor: LENZ Therapeutics, Inc • Aim: Symptom relief
Last updated Jun 27, 2026 12:33 UTC
-
New eye drops zap allergy itch in just minutes
Symptom relief CompletedThis study tested an eye drop called reproxalap in 131 adults with moderate-to-severe seasonal eye allergies. Participants were exposed to ragweed pollen in a special chamber to trigger symptoms. The eye drop was compared to a placebo (no active ingredient) to see if it reduced i…
Phase: PHASE3 • Sponsor: Aldeyra Therapeutics, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:32 UTC
-
New drug could soothe cat allergy eyes
Symptom relief CompletedThis study tested two experimental drugs, REGN1908 and REGN1909, mixed together to reduce eye allergy signs and symptoms in people with cat allergies. The goal was to see how safe and effective the drug is compared to a placebo. The study included 64 participants with a history o…
Phase: PHASE3 • Sponsor: Regeneron Pharmaceuticals • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
Vision booster? citicoline tested after glaucoma surgery
Symptom relief CompletedThis study looked at whether a supplement called citicoline can improve vision in people with glaucoma after they have eye surgery. Six adults took either citicoline or a placebo for a short time. The goal was to see if citicoline could help protect the optic nerve and improve vi…
Phase: NA • Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Wheat-Free diet shows promise for Sjogren's sufferers in small study
Symptom relief CompletedThis pilot study tested whether a wheat-free and milk-free diet could reduce symptoms in people with Sjogren's syndrome, an autoimmune disease. Thirty participants were randomly assigned to either the special diet or a control diet. After two months, those on the wheat-free diet …
Phase: NA • Sponsor: University of Palermo • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Could a nasal spray soothe dry eyes?
Symptom relief CompletedThis study tested whether a nasal spray containing varenicline (OC-01) can improve tear film quality and reduce dryness in people with dry eye disease. Fifty adults used either the active spray or a placebo. Researchers measured tear film changes and symptom scores shortly after …
Phase: PHASE4 • Sponsor: Stephenson Eye Associates • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Acupuncture with a jolt: new hope for dry eyes?
Symptom relief CompletedThis study tested whether electroacupuncture (a type of acupuncture with mild electric pulses) can improve symptoms of mild-to-moderate dry eye. 168 adults received either real or sham electroacupuncture. Researchers measured tear film stability and other eye health markers to se…
Phase: NA • Sponsor: Shanghai Institute of Acupuncture, Moxibustion and Meridian • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Could a melt tablet replace IV sedation for eye surgery?
Symptom relief CompletedThis study looked at whether a melt tablet containing midazolam and ketamine works as well as IV sedation for keeping people calm and pain-free during cataract surgery. Over 1,100 adults aged 55-80 took part. Researchers measured sedation levels, pain scores, and whether extra pa…
Sponsor: Vance Thompson Vision • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Tuning in: music may boost focus for Kids' glaucoma eye exams
Symptom relief CompletedThis study looked at whether playing music helps children with glaucoma stay focused during a visual field exam (a test that checks side vision). 38 children took part, and researchers measured how often they made mistakes or lost focus. The goal was to see if music could make th…
Phase: NA • Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
One shot beats daily drops for Post-Cataract inflammation?
Symptom relief CompletedThis study tested whether a single steroid injection given during cataract surgery works as well as standard steroid eye drops to control inflammation afterward. 72 adults aged 50 and older having routine cataract surgery took part. The goal was to see if the injection could simp…
Phase: NA • Sponsor: Damascus University • Aim: Symptom relief
Last updated Jun 27, 2026 12:28 UTC
-
New eye drops aim to soothe dry eye sufferers
Symptom relief CompletedThis study tested whether BRM421 eye drops can safely reduce the signs and symptoms of dry eye compared to a placebo. 220 adults with dry eye for at least 6 months received either the active drops or a placebo. The main outcomes were changes in corneal staining (eye surface damag…
Phase: PHASE2, PHASE3 • Sponsor: BRIM Biotechnology Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:28 UTC
-
New eye drop shows promise for dry eye sufferers
Symptom relief CompletedThis study tested whether BRM421 eye drops can safely ease the signs and symptoms of dry eye. 157 adults with dry eye for at least 6 months received either the active drops or a placebo. The trial measured changes in corneal staining and discomfort scores. Results suggest the dro…
Phase: PHASE2 • Sponsor: BRIM Biotechnology Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:28 UTC
-
Warm eye masks show promise for dry eye sufferers
Symptom relief CompletedThis study tested whether far infrared eye masks placed on acupoints around the eyes could improve dry eye symptoms. Thirty-one adults with dry eye disease used the masks, and researchers measured tear film stability, gland health, and symptom scores before and after one month of…
Phase: NA • Sponsor: China Medical University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC
-
New eye drop offers hope for dry eye sufferers
Symptom relief CompletedThis study tested an eye drop called HBM9036 in 577 Chinese adults with moderate to severe dry eye. The goal was to see if it reduces eye surface damage and improves symptoms better than a placebo. Participants used the drops for about two months, and doctors measured changes in …
Phase: PHASE3 • Sponsor: Harbour BioMed (Guangzhou) Co. Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC
-
New eyedrops aim to soothe dry, irritated eyes
Symptom relief CompletedThis early-stage trial tested an experimental eyedrop called INV-102 in 84 adults with moderate dry eye disease. The study had two parts: first, checking safety at different doses, and second, seeing if the drops improve eye dryness symptoms after two weeks. Participants used the…
Phase: PHASE1, PHASE2 • Sponsor: Invirsa, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC
-
Laser showdown: which LASIK flap maker is better?
Symptom relief CompletedThis study compared two types of lasers used to create the flap in LASIK eye surgery for nearsightedness. 120 adults each had one eye treated with the Intralase laser and the other with the Visumax laser. The goal was to see which laser caused less discomfort during surgery and l…
Sponsor: Singapore Eye Research Institute • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Double eye numbing shot tested for Pain-Free cataract surgery
Symptom relief CompletedThis study tested a numbing injection given around both eyes to see if it safely controls pain during cataract surgery. Fifty adults received the injection, and researchers measured their pain and satisfaction. The goal was to find a better way to keep patients comfortable during…
Sponsor: Tanta University • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Simple nursing tricks slash pain during diabetic eye laser treatment
Symptom relief CompletedThis study tested a nursing intervention designed to help patients relax and feel more comfortable during diabetic retinal laser surgery. 136 adults received either standard care or extra support including guided breathing, clear communication, and reassurance. The goal was to se…
Phase: NA • Sponsor: Joint Shantou International Eye Center of Shantou University and the Chinese University of Hong Kong • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
New lens offers sharper sight at every distance after cataract surgery
Symptom relief CompletedThis study tested three types of artificial lenses implanted during cataract surgery to see which gives the best vision at far, middle, and near distances. 197 people with cataracts in both eyes received one of the three lens types. The goal was to improve vision and reduce the n…
Sponsor: Sakarya Yenikent State Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Could a tiny eye insert replace drops for kids after surgery?
Symptom relief CompletedThis early study tested a tiny dexamethasone insert placed in the tear duct of 15 children after retinal surgery or laser treatment. The goal was to see if it could safely reduce pain and eye inflammation. Researchers measured pain using a standard scale and tracked any side effe…
Phase: EARLY_PHASE1 • Sponsor: Lejla Vajzovic, MD, FASRS • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Can a simple drug cut bleeding in jaw surgery?
Symptom relief CompletedThis study tested whether giving EXACYL before surgery can reduce bleeding during and after jaw realignment surgery. 157 adults took part in a double-blind, placebo-controlled Phase 3 trial. The goal was to see if the drug makes surgery safer and more comfortable.
Phase: PHASE3 • Sponsor: University Hospital, Lille • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
New drug cocktail aims to stop itchy eyes from birch pollen
Symptom relief CompletedThis study tested two experimental drugs, REGN5713 and REGN5715, given together to reduce eye allergy symptoms caused by birch pollen. Fifty-four adults with a history of moderate to severe birch pollen allergy received the drug combo or a placebo. The main goal was to see if the…
Phase: PHASE3 • Sponsor: Regeneron Pharmaceuticals • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
New lens implant shows promise for clearer vision after cataract surgery
Symptom relief CompletedThis study looked at the safety and effectiveness of a special lens (aspicio™) implanted during cataract surgery. Thirty adults who already had the lens were checked at least 3 months after surgery. The goal was to see how well they could see at different distances and if there w…
Sponsor: ICARES Medicus, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:10 UTC
-
Special contact lenses aim to soothe dry eyes
Symptom relief CompletedThis study tested whether scleral lenses treated with a special coating called Hydra-PEG can improve comfort and reduce dryness in people with dry eye. 46 participants wore two types of lenses over several weeks and rated their comfort on a scale. The goal was to see if the coate…
Phase: NA • Sponsor: CooperVision International Limited (CVIL) • Aim: Symptom relief
Last updated Jun 27, 2026 12:09 UTC
-
Contact lens study checks how well they work for nearsighted and farsighted people
Symptom relief CompletedThis study looked at how well contact lenses perform and how comfortable people find them. It included 36 adults who already wear soft contact lenses and have nearsightedness or farsightedness. Participants wore the lenses and had their vision tested after 10 hours.
Phase: NA • Sponsor: CooperVision International Limited (CVIL) • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
Which contact lens wins? study compares two popular multifocals for aging eyes
Symptom relief CompletedThis study compared two types of soft multifocal contact lenses (Proclear 1 Day and Clariti 1 Day) to see which one people liked better. 67 adults who already wore contact lenses and needed reading glasses tried both lenses and rated their overall satisfaction. The goal was to he…
Phase: NA • Sponsor: CooperVision International Limited (CVIL) • Aim: Symptom relief
Last updated Jun 27, 2026 12:06 UTC
-
Which lens is better? study puts two soft contacts to the test
Symptom relief CompletedThis study compared two types of soft contact lenses to see which one people liked better for vision and comfort. 52 adults who wear contacts took part. They rated the lenses on a scale from 0 to 100. The goal was to find out if one lens performed better in everyday use.
Phase: NA • Sponsor: CooperVision, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:06 UTC
-
Which lens feels better? study puts two popular contacts to the test
Symptom relief CompletedThis study tested how comfortable two different daily soft contact lenses feel right after putting them in. 45 adults who already wear contacts and have mild to moderate nearsightedness rated each lens on a 0-100 comfort scale. The goal was to see if one lens feels better than th…
Phase: NA • Sponsor: CooperVision, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:05 UTC
-
Which contact lens feels better? study puts two brands to the test
Symptom relief CompletedThis study tested two types of soft contact lenses—Proclear 1 Day and MyDay sphere—to see which one feels more comfortable. 44 adults who already wear contact lenses rated comfort on a scale from 0 to 100. The goal was simply to compare the lenses, not to treat or cure any eye di…
Phase: NA • Sponsor: CooperVision International Limited (CVIL) • Aim: Symptom relief
Last updated Jun 27, 2026 12:05 UTC
-
New contact lens study tests better comfort for astigmatism sufferers
Symptom relief CompletedThis study tested two types of soft contact lenses—Myday Sphere and Myday Toric—in 32 people who already wear spherical lenses but have low astigmatism. Participants wore each lens type for one week and rated comfort on a 0-100 scale. The goal was to see if the toric lens offers …
Phase: NA • Sponsor: CooperVision International Limited (CVIL) • Aim: Symptom relief
Last updated Jun 27, 2026 12:05 UTC
-
Could a new oat variety be safe for celiac patients?
Symptom relief CompletedThis study tested whether a low-immunogenic oat variety called Saul is well-tolerated by adults with celiac disease who are in remission. Forty participants ate 50 grams of gluten-free Saul oat flakes daily for 14 days. Researchers tracked symptoms and blood markers to see if the…
Phase: NA • Sponsor: Faculty Hospital Kralovske Vinohrady • Aim: Symptom relief
Last updated Jun 27, 2026 12:04 UTC
-
New eye drop could ease pain of Sight-Saving injections
Symptom relief CompletedThis study tested a new antiseptic called IRX-101 against the standard povidone-iodine in 155 people receiving eye injections for retinal disease. The goal was to see if IRX-101 reduces pain and corneal damage after the injection. Researchers measured safety and corneal staining …
Phase: PHASE2 • Sponsor: iRenix Medical, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:03 UTC
-
Meditation app eases anxiety in uveitis patients
Symptom relief CompletedThis study tested whether a smartphone meditation app (Calm Health) could help reduce anxiety and depression in 100 adults with non-infectious uveitis, an inflammatory eye disease. Participants used the app and reported their symptoms. The goal was to see if digital mindfulness c…
Phase: NA • Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated Jun 27, 2026 12:03 UTC
-
Eye drops could replace reading glasses for presbyopia
Symptom relief CompletedThis Phase 2 trial tested three different eye drop formulas—BRIMOCHOL, BRIMOCHOL F, and carbachol alone—to see if they could improve near vision in people with presbyopia (age-related difficulty seeing up close). The study enrolled 18 adults who received a single drop in each eye…
Phase: PHASE2 • Sponsor: Visus Therapeutics • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
Could a simple eyelid wipe soothe dry eyes?
Symptom relief CompletedThis study tested three ways to use an eyelid wipe soaked with IVW-1001, a dry eye treatment, in 30 people with dry eye disease. Researchers measured changes in tear production and checked for any vision changes. The goal was to find the best wiping technique for safety and sympt…
Phase: PHASE2 • Sponsor: IVIEW Therapeutics Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
Eye drop showdown: best way to widen pupils in diabetic patients revealed
Symptom relief CompletedThis study tested four different ways of giving dilating eye drops to 84 diabetic patients who needed eye exams for diabetic retinopathy. The goal was to find which method works best to get the pupil large enough for a good exam. Researchers measured pupil size and watched for si…
Phase: NA • Sponsor: Burapha University • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
Wrinkle-Zapping device may double as dry eye remedy
Symptom relief CompletedThis pilot study tested whether Tixel, a device used to treat wrinkles around the eyes, could also improve dry eye symptoms. 75 adults with mild to moderate wrinkles and dry eye received the standard Tixel treatment. Researchers measured tear film stability and dry eye questionna…
Phase: NA • Sponsor: Aston University • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
New eyelid wipe dosing methods tested for dry eye relief
Symptom relief CompletedThis study tested three different ways to use a medicated eyelid wipe (IVW-1001) for people with dry eye disease. Fifteen adults with dry eye took part. The main goal was to see how safe and tolerable the different dosing techniques were, and how well they improved tear productio…
Phase: PHASE2 • Sponsor: IVIEW Therapeutics Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
Warm IV fluid eases pain for emergency eye patients
Symptom relief CompletedThis study tested whether warming the intravenous (IV) mannitol fluid before giving it to people with sudden high eye pressure can reduce pain and improve comfort. 142 adults took part, with half getting warmed mannitol and half getting standard (room temperature) mannitol. The g…
Phase: NA • Sponsor: Joint Shantou International Eye Center of Shantou University and the Chinese University of Hong Kong • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
New eye drops may replace reading glasses for millions
Symptom relief CompletedThis study tested whether a special eye drop (esculin and digitalis glycosides) can improve near vision in people with presbyopia, the age-related difficulty focusing on close objects. 62 adults aged 40-55 took part. The goal was to see if the drops help the eye's focusing muscle…
Phase: PHASE4 • Sponsor: Shanxi Eye Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
New contact lens aims to beat digital eye fatigue
Symptom relief CompletedThis study tested two types of stenfilcon A contact lenses to see if one reduces eye strain from digital screens better than the other. Thirty adults who already wear contacts and have computer vision syndrome wore each lens design for five days. The lenses were compared using qu…
Phase: NA • Sponsor: Southern College of Optometry • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
Walking away from Sjögren's fatigue: study tests simple exercise
Symptom relief CompletedThis study looked at whether regular aerobic exercise, like walking, can reduce fatigue in women with primary Sjögren's syndrome. Forty-five women participated in a 16-week program. Researchers measured changes in fatigue, mood, and physical fitness.
Phase: NA • Sponsor: Samira Tatiyama Miyamoto, PhD • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
Warm compresses vs. High-Tech eye gadgets: which best treats dry eye?
Symptom relief CompletedThis study tested three treatments for meibomian gland dysfunction, a common cause of dry eye. 374 adults with mild-to-moderate dry eye were randomly assigned to receive either vectored thermal pulsation (a device that heats and massages the eyelids), intense pulsed light therapy…
Phase: NA • Sponsor: Chinese University of Hong Kong • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC
-
Laser showdown: which eye surgery fixes mixed astigmatism best?
Symptom relief CompletedThis study compared two types of laser eye surgery—FS-LASIK and single-step TransPRK—for correcting mixed astigmatism, a condition where the eye's shape causes blurry vision at all distances. Thirty-nine people received one of the two procedures, and researchers measured their vi…
Sponsor: Assiut University • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC
-
New eye drops for dry eye pass safety check in small trial
Symptom relief CompletedThis study tested the safety of AR-15512 eye drops in 55 people with dry eye disease. Participants received the drops at different temperatures and with eyes open or closed to see if these factors affect side effects. The goal was to measure how many people had eye-related side e…
Phase: PHASE3 • Sponsor: Alcon Research • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC
-
New contact lens could reduce need for reading glasses in presbyopia
Symptom relief CompletedThis study tested a new contact lens designed to help people with presbyopia (age-related blurry near vision) see clearly at both far and close distances, potentially reducing the need for bifocals or reading glasses. 78 adults aged 45 to 70 who already wear soft contact lenses t…
Phase: NA • Sponsor: Bruno Vision Care • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC
-
Can a herbal mist soothe dry eyes? new study investigates
Symptom relief CompletedThis study tested whether a fine mist made from traditional Chinese herbs can help people with dry eye disease. 200 adults received either the herbal mist, a placebo mist, or standard eye drops for 4 months. Researchers measured symptom scores and tear film stability to see if th…
Phase: NA • Sponsor: Chinese University of Hong Kong • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC
-
Can a phone app ease the emotional toll of glaucoma?
Symptom relief CompletedThis study tested a mobile app that teaches Acceptance and Commitment Therapy (ACT) to help people with glaucoma cope with anxiety, depression, and emotional distress. Researchers worked with 28 patients to see if the app was acceptable and easy to use. The goal was to lay the gr…
Phase: NA • Sponsor: Duke University • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC
-
New lens implant helps presbyopia patients ditch reading glasses
Symptom relief CompletedThis study tested a special lens implant (EVO+ Visian ICL) to improve near vision in 41 adults with presbyopia, an age-related condition that makes it hard to see up close. The lens is placed behind the iris and in front of the eye's natural lens. Six months after surgery, most e…
Phase: NA • Sponsor: Staar Surgical Company • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
New eye drops show promise for dry eye sufferers
Symptom relief CompletedThis early-phase trial tested YM-101 eye drops in 30 adults with dry eye syndrome. Participants received either high or low dose YM-101 plus artificial tears, then switched to placebo after a washout period. The study measured changes in corneal staining, tear break-up time, and …
Phase: EARLY_PHASE1 • Sponsor: Eye & ENT Hospital of Fudan University • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
Could these eye drops replace reading glasses? new trial tests a daily drop for aging eyes
Symptom relief CompletedThis completed Phase 3 trial tested whether phentolamine eye drops (Nyxol) can improve near vision in people with presbyopia, the age-related loss of ability to focus on close objects. 569 adults aged 45 to 64 used the drops or a placebo once daily for 8 days. The main goal was t…
Phase: PHASE3 • Sponsor: Ocuphire Pharma, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
New eye drops could replace reading glasses for millions
Symptom relief CompletedThis Phase 3 trial tested Nyxol eye drops, alone or with low-dose pilocarpine, in 333 adults aged 40–64 with presbyopia (age-related difficulty seeing up close). The goal was to improve near vision without losing distance vision. Participants received drops and were measured afte…
Phase: PHASE3 • Sponsor: Ocuphire Pharma, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
Can your own blood soothe dry eyes? new study says maybe.
Symptom relief CompletedThis study tested whether eye drops made from a patient's own blood (autologous serum) can relieve severe dry eye better than standard artificial tears. 46 adults with severe dry eye tried both diluted (20%) and full-strength (100%) serum drops, as well as artificial tears. The m…
Phase: NA • Sponsor: University Hospital, Ghent • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
New eye drops promise sharper night vision for Post-LASIK patients
Symptom relief CompletedThis study tested an eye drop (POS) in 200 adults who had poor night vision after LASIK or similar eye surgery. The goal was to see if the drops could help them see better in dim light, reducing problems like glare and halos. Participants used the drops for 15 days and had their …
Phase: PHASE3 • Sponsor: Ocuphire Pharma, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
Eyedrop lifts droopy eyelids after facial paralysis?
Symptom relief CompletedThis study tested an FDA-approved eyedrop (oxymetazoline 0.1%) in 36 adults with eyelid droop caused by facial nerve miswiring after paralysis. The goal was to see if the drop could temporarily raise the eyelid, improve vision, and reduce abnormal muscle spasms. Researchers measu…
Phase: PHASE3 • Sponsor: Milton S. Hershey Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
New cataract lens helps patients see clearly without glasses
Symptom relief CompletedThis study tested a special lens implanted during cataract surgery to see if it improves vision at far, middle, and close distances. Thirty adults with cataracts received the lens in both eyes. Researchers measured their vision and satisfaction 1 and 3 months after surgery.
Phase: NA • Sponsor: Benha University • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
Could insulin eye drops ease dry eye? new trial results
Symptom relief CompletedThis study tested if insulin eye drops can safely and effectively treat moderate to severe dry eye disease. 116 adults received either insulin drops, standard cyclosporin drops, or artificial tears (placebo) for 6 months. The main goal was to see if insulin drops improved corneal…
Phase: PHASE4 • Sponsor: Barbara Burgos Blasco • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC
-
New eye drops take on dry eye in Head-to-Head trial
Symptom relief CompletedThis phase 3 trial tested whether a new eye drop called HUC3-053 works as well as an existing drop (Hyalein) for dry eye. 297 adults used the drops 5-6 times daily for 12 weeks. The study measured changes in eye surface staining and other signs of dry eye.
Phase: PHASE3 • Sponsor: Huons Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC
-
Yellow screen shields eyes from digital strain, study finds
Symptom relief CompletedThis study tested whether a special yellow-light, anti-glare phone screen could reduce eye strain and dryness caused by using a phone for 2 hours in a dim room. 70 adults with mild nearsightedness took part. Researchers measured tear quality, eye redness, and other signs of eye f…
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC
-
Can more drops beat dry eye? new study tests three schedules
Symptom relief CompletedThis Phase 2 study tested three different dosing schedules of Lagricel Ofteno eye drops (sodium hyaluronate 0.4%) in 141 people with mild to moderate dry eye. Participants used the drops either twice, four times, or six times a day. The main goal was to see which schedule best im…
Phase: PHASE2 • Sponsor: Laboratorios Sophia S.A de C.V. • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC
-
Teaching seniors eye drop skills may boost cataract recovery
Symptom relief CompletedThis study tested whether giving older adults structured education on eye drop use and self-care after cataract surgery improves recovery. Eighty participants aged 65 to 85 were split into two groups: one received routine care, the other added periodic education sessions. Researc…
Phase: NA • Sponsor: Cumhuriyet University • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC
-
New lens promises better sight at all distances for cataract patients
Symptom relief CompletedThis study tested a special type of artificial lens (TECNIS Eyhance IOL) in 62 adults aged 45-75 who had cataract surgery. The goal was to see how well the lens helps people see clearly at different distances, from close up to far away. Researchers measured vision at nine distanc…
Sponsor: Democritus University of Thrace • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC
-
Does digital assistance improve lens implant results? new study explores.
Symptom relief CompletedThis study looked at 40 people over 45 who had cataract surgery with a special lens that helps with both near and far vision. Half of them had the surgery with digital assistance, and half without. The goal was to see if the digital help led to better vision or more satisfaction …
Sponsor: Democritus University of Thrace • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC
-
New eye drops could replace reading glasses for presbyopia
Symptom relief CompletedThis Phase 3 trial tested LNZ101 eye drops in 229 people aged 45-75 with presbyopia, a condition that makes it hard to see up close. The drops combine aceclidine and brimonidine to temporarily improve near vision. The main goal was to see if participants could read three lines be…
Phase: PHASE3 • Sponsor: LENZ Therapeutics, Inc • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC
-
New contact lens study checks fit and movement for young eyes
Symptom relief CompletedThis study tested two types of soft contact lenses in 73 children and teenagers (ages 8 to 18) with nearsightedness. Researchers checked how well the lenses stayed centered on the eye and moved with each blink after at least three hours of wear. The goal was to see which lens per…
Phase: NA • Sponsor: CooperVision, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC
-
Eye gel may replace painful needle in pterygium surgery
Symptom relief CompletedThis study tested whether a numbing gel (lidocaine) works as well as a needle injection for pain relief during pterygium surgery. 41 adults having pterygium removal took part. The goal was to see if the gel causes less pain and eye dryness after surgery.
Phase: PHASE4 • Sponsor: Vrije Universiteit Brussel • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC
-
Eye drops may ease pain in second cataract surgery
Symptom relief CompletedThis study tested whether anti-inflammatory eye drops (pranoprofen or prednisolone acetate) can reduce pain during second-eye cataract surgery compared to standard lubricating drops. 126 adults aged 50 and older who had already had one cataract surgery received the drops before t…
Phase: PHASE4 • Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC
-
Eye drop showdown: which one beats dry eye?
Symptom relief CompletedThis study tested three different eye drops (Humylub Ofteno PF, Hyabak, and Lagricel Ofteno PF) in 182 people with mild to moderate dry eye. Participants used the drops four times a day for 30 days. The main goal was to see if Humylub was as good as the others at reducing dry eye…
Phase: PHASE4 • Sponsor: Laboratorios Sophia S.A de C.V. • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC
-
New eye insert may ease pain after cataract surgery
Symptom relief CompletedThis study tested whether a tiny eye insert called DEXTENZA, placed after cataract surgery, works better than standard eye drops alone for reducing pain and swelling. Fifty adults having cataract surgery took part. The insert slowly releases medicine over time, aiming to improve …
Phase: PHASE4 • Sponsor: Nicole Fram M.D. • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC
-
Which contact lens is best for astigmatism? small study pits two designs Head-to-Head
Symptom relief CompletedThis completed study compared two types of soft toric contact lenses for people with astigmatism. Forty-two participants wore each lens briefly and rated them on comfort, vision, and overall satisfaction. The goal was to see which lens performed better in the short term.
Phase: NA • Sponsor: CooperVision International Limited (CVIL) • Aim: Symptom relief
Last updated Jun 27, 2026 09:06 UTC
-
Gut health hack: supplement shows promise for dry eyes
Symptom relief CompletedThis study tested whether a dietary supplement could improve dry eye symptoms by changing the bacteria in the gut. Twenty adults with dry eye disease took the supplement for 8 weeks. Researchers measured tear production and eye surface health before and after treatment. The goal …
Phase: NA • Sponsor: Varol TUNALI • Aim: Symptom relief
Last updated Jun 27, 2026 09:06 UTC
-
New eye drops aim to soothe dry eyes with fewer doses
Symptom relief CompletedThis completed study tested whether Reinnerva/Lubristil+G eye drops work better than Vismed for people with dry eyes. Forty adults with dry eye symptoms used one drop in each eye twice daily (Reinnerva/Lubristil+G) or four times daily (Vismed) for 60 days. Researchers measured te…
Phase: NA • Sponsor: Medivis SRL • Aim: Symptom relief
Last updated Jun 27, 2026 09:06 UTC
-
Electric current delivers lutein to eyes in AMD study
Symptom relief CompletedThis study looked at whether a treatment called transscleral lutein iontophoresis (TSLI) is safe and helpful for people with a specific type of age-related macular degeneration (AMD) that includes reticular pseudodrusen. Thirty participants received the treatment, and their visio…
Sponsor: Mario Damiano Toro • Aim: Symptom relief
Last updated Jun 27, 2026 09:05 UTC
-
Could these new drops soothe dry eyes?
Symptom relief CompletedThis study tested a new eye drop formula in 188 adults with mild to moderate dry eye disease. Participants used the drops for 30 days and reported how much their symptoms bothered them. The goal was to see if the drops safely improve comfort.
Phase: NA • Sponsor: Alcon Research • Aim: Symptom relief
Last updated Jun 27, 2026 09:05 UTC
-
Can a simple gel improve eyelid scars after surgery?
Symptom relief CompletedThis study tested whether silicone gel helps reduce scarring after eyelid surgery. 132 patients applied silicone gel to one eye and a placebo (Aquaphor) to the other, without knowing which was which. Doctors and patients rated scar redness, elevation, and pigmentation over 6 mont…
Phase: NA • Sponsor: Montefiore Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 09:05 UTC
-
Pre-Surgery phone chat eases eye operation jitters
Symptom relief CompletedThis study looked at whether a structured counseling session over the phone before cataract surgery could lower patients' anxiety and improve their recovery. 128 adults scheduled for cataract surgery took part. Half received the extra phone counseling, while the other half got st…
Phase: NA • Sponsor: Mehtap ÖZTÜRK BAKIR • Aim: Symptom relief
Last updated Jun 27, 2026 09:05 UTC
-
Tiny drops, big savings: new study tests smaller eye drops for numbing
Symptom relief CompletedThis study tested whether a special adaptor that makes smaller eye drops works as well as standard drops for numbing the eye. 56 adults received numbing drops in each eye—one with the standard bottle and the other with the Nanodropper adaptor. Researchers measured how numb each e…
Phase: PHASE4 • Sponsor: Columbia University • Aim: Symptom relief
Last updated Jun 27, 2026 09:05 UTC
-
New eye drops aim to soothe dry eye sufferers
Symptom relief CompletedThis study tested a new eye treatment called TTAX03 in 74 people with mild to moderate dry eye disease. The goal was to see if it is safe and if it can reduce eye dryness and damage. Participants received either a single dose of TTAX03 or a saline (salt water) control and were ch…
Phase: PHASE2 • Sponsor: BioTissue Holdings, Inc • Aim: Symptom relief
Last updated Jun 27, 2026 09:04 UTC
-
New eye drops aim to soothe dry eyes
Symptom relief CompletedThis phase 2 trial tested two strengths of rhNGF eye drops against a placebo in 317 adults with moderate-to-severe dry eye disease. Participants used the drops three times a day for 4 weeks, followed by 4 weeks of monitoring. The goal was to see if the drops could improve dry eye…
Phase: PHASE2 • Sponsor: Dompé Farmaceutici S.p.A • Aim: Symptom relief
Last updated Jun 27, 2026 09:04 UTC
-
New eyelid wipe aims to soothe dry eyes
Symptom relief CompletedThis study tested a new medicated eyelid wipe called IVW-1001 in 150 adults with dry eye disease. Participants used either a low dose, a higher dose, or a placebo wipe. The goal was to see if the wipe is safe and can improve tear production and eye comfort.
Phase: PHASE1, PHASE2 • Sponsor: IVIEW Therapeutics Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 09:04 UTC
-
Eye drops Face-Off: which works better for dry eyes during cataract surgery?
Symptom relief CompletedThis study tested two different eye drop treatments for people with dry eye disease who were having cataract surgery. One group used a single medication (rebamipide), while the other used a combination of two medications (diquafosol and cyclosporine). The goal was to see which ap…
Phase: PHASE4 • Sponsor: Samsung Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 09:03 UTC
-
New eye drops aim to boost tears in dry eye sufferers
Symptom relief CompletedThis completed Phase 3b trial tested AR-15512 eye drops in 81 adults with dry eye disease. The goal was to see if a single dose could quickly increase tear production, measured by tear meniscus height. The study was open-label, meaning everyone knew they were getting the active d…
Phase: PHASE3 • Sponsor: Alcon Research • Aim: Symptom relief
Last updated Jun 27, 2026 09:03 UTC
-
Berry extract shows promise for aging eyes
Symptom relief CompletedThis study tested whether a daily berry extract supplement (from aronia, honeyberry, and bilberry) could improve vision in 27 adults aged 50+ with presbyopia (age-related blurry near vision). Participants took the supplement or a placebo for 6 weeks each, with a 5-week break in b…
Phase: NA • Sponsor: Wroclaw Medical University • Aim: Symptom relief
Last updated Jun 27, 2026 09:02 UTC
-
Laser zaps away reading glasses for Post-Cataract patients?
Symptom relief CompletedThis study tested a low-energy femtosecond laser (the Perfector device) to treat presbyopia in 19 people who already had monofocal lens implants from cataract surgery. The goal was to improve near and intermediate vision without harming distance vision. Participants were measured…
Phase: NA • Sponsor: Perfect Lens, LLC • Aim: Symptom relief
Last updated Jun 27, 2026 09:02 UTC
-
Eye surgery aftermath: new tool measures corneal strength changes
Knowledge-focused CompletedThis study measured how three common eye surgeries—LASIK, PRK, and corneal cross-linking (CXL)—change the stiffness of the cornea. Using a device called Corvis ST, researchers assessed 150 adults who had undergone one of these procedures at least a month earlier. The goal was to …
Sponsor: Beni-Suef University • Aim: Knowledge-focused
Last updated Jul 03, 2026 23:00 UTC
-
Scientists dive into rare cholesterol disorders to uncover clues
Knowledge-focused CompletedThis study looks at rare genetic disorders where the body can't make cholesterol properly, which can cause birth defects and learning problems. Researchers collect blood, urine, and tissue samples from affected people and their families to learn more about these conditions. The g…
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) • Aim: Knowledge-focused
Last updated Jul 03, 2026 23:00 UTC
-
Rare genetic disorder studied for clues to better care
Knowledge-focused CompletedThis study looked at Smith-Lemli-Opitz syndrome (SLOS), a rare genetic condition that affects cholesterol production and causes birth defects and intellectual disabilities. Researchers enrolled 130 patients and their mothers to learn more about the disease's progression, genetic …
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) • Aim: Knowledge-focused
Last updated Jul 03, 2026 23:00 UTC
-
Could lower eye pressure during cataract surgery reduce corneal damage?
Knowledge-focused CompletedThis study investigates whether using a lower, more natural eye pressure during cataract surgery reduces trauma to the cornea compared to traditional high-pressure methods. The Active Sentry device helps maintain stable pressure by sensing changes in the eye. Researchers will mea…
Phase: NA • Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Acne Drug's hidden toll on the eye revealed
Knowledge-focused CompletedThis study looks at how isotretinoin, a vitamin A-based acne medication, affects eye structures and tear production in people with severe cystic acne. Participants receive standard treatment and undergo eye exams, including dry eye tests and advanced imaging, before and during th…
Phase: NA • Sponsor: Demet Mutlu • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Eye disease study tracks vision loss over years
Knowledge-focused CompletedThis study followed 20 adults aged 55 and older with geographic atrophy, an advanced form of age-related macular degeneration that causes central vision loss. Researchers measured how the damaged area in the eye changed over nearly 4 years using eye exams and photos. The goal was…
Sponsor: National Eye Institute (NEI) • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Night vision test could spot early eye disease
Knowledge-focused CompletedThis study looked at whether a simple test measuring how fast eyes recover in the dark can help track early to middle dry age-related macular degeneration (AMD). Researchers followed 217 adults aged 50 and older, with or without AMD, for up to 5 years. The goal was to see if chan…
Sponsor: National Eye Institute (NEI) • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Could better fitness keep your eyes healthy?
Knowledge-focused CompletedThis study looks at whether being more fit is linked to lower eye pressure in healthy adults. Researchers measured eye pressure and fitness in nearly 3,000 people aged 18 to 70. The goal is to see if better cardiorespiratory fitness might help protect eye health.
Sponsor: Sichuan Academy of Medical Sciences • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Could your gut bacteria be linked to eye disease?
Knowledge-focused CompletedThis study looked at the natural bacteria in the gut of 131 adults with and without uveitis, an inflammatory eye disease. Researchers collected stool and blood samples and performed eye exams to see if differences in gut bacteria are linked to eye inflammation. No treatment was g…
Sponsor: National Eye Institute (NEI) • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Tiny doses of atropine: unlocking the Eye's response to slow nearsightedness
Knowledge-focused CompletedThis study investigates how low doses of atropine eye drops (0.01%, 0.02%, and 0.05%) affect pupil size and the eye's ability to focus in healthy adults aged 18 to 40. Researchers aim to compare different dosing methods and recovery times, and to see if iris color influences the …
Phase: PHASE1 • Sponsor: University of California, Berkeley • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Sjögren's muscle mystery: study aims to classify inflammatory involvement
Knowledge-focused CompletedThis study looked at 54 people with primary Sjögren's syndrome who also had muscle inflammation. Researchers wanted to see how many met the official criteria for inflammatory myopathies. The goal was to better understand and classify muscle disease in Sjögren's patients.
Sponsor: University Hospital, Brest • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
Surgeons try apple vision pro during cataract operations
Knowledge-focused CompletedThis study tested whether surgeons can safely use an Apple Vision Pro headset to view a microscope during cataract and other eye surgeries. 45 adults having elective eye surgery took part. The goal was to see if the headset is safe and comfortable for the surgeon, not to change h…
Phase: NA • Sponsor: Sharp HealthCare • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
New eye scanner aims to sharpen view of retinal disease
Knowledge-focused CompletedThis trial tests a new device called P200TxE that takes detailed images of the back of the eye. Researchers want to see how well it captures images in people with retinal diseases like glaucoma or macular degeneration. The study involves adults aged 22 and older who have been dia…
Phase: NA • Sponsor: Optos, PLC • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
AMD Patients' knowledge gaps revealed in new study
Knowledge-focused CompletedThis study looks at what people with age-related macular degeneration (AMD) know about their disease and what they need to manage it better. Researchers will survey and interview 118 patients to understand their knowledge, daily challenges, and support needs. The goal is to use t…
Phase: NA • Sponsor: University Hospital, Limoges • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Eye surgery showdown: which technique spares more corneal cells?
Knowledge-focused CompletedCataracts cloud the eye's lens and can lead to blindness if untreated. This study compared two common surgical techniques—Divide-and-Conquer and Subluxation—to see which causes less damage to the cornea's inner cell layer. 294 adults having cataract surgery took part, and researc…
Phase: NA • Sponsor: Centre Hospitalier Régional Metz-Thionville • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Scanners peer into brains of gaucher and parkinson patients
Knowledge-focused CompletedThis completed study used PET and MRI scans to compare brain dopamine function in people with Gaucher disease or Parkinson disease, their family members, and healthy volunteers. Researchers aimed to see if certain genetic mutations cause early changes in dopamine storage. The stu…
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Doctors tested in fake coma emergency – Here's what they found
Knowledge-focused CompletedThis study watched 50 doctors from different specialties as they treated a mannequin pretending to be in a coma. The goal was to see how well their actions matched current medical guidelines. The results could help improve training and recommendations for real-life coma care.
Sponsor: University Hospital, Basel, Switzerland • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Could Mom's pregnancy exposures cause Baby's eye defect?
Knowledge-focused CompletedThis study explores whether things a mother is exposed to during early pregnancy might cause uveal coloboma, a rare eye condition present at birth. Researchers will survey mothers of affected children and compare their answers to historical data. The goal is to identify possible …
Sponsor: National Eye Institute (NEI) • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
AI boosts eye Doctors' accuracy in reading retinal scans?
Knowledge-focused CompletedThis study tested whether artificial intelligence (AI) can help doctors detect retinal diseases from ultra-widefield eye images. 462 images were read by four eye doctors with different experience levels, both with and without AI assistance. The goal was to see if AI improves accu…
Sponsor: Xiamen Ophthalmology Center Affiliated to Xiamen University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Eye imaging showdown: which device measures macular damage best?
Knowledge-focused CompletedThis study compared two different eye imaging machines (Clarus and Optos) to see how well they measure geographic atrophy, a form of vision loss from age-related macular degeneration. Researchers enrolled 62 patients and took images with each device, then compared the measurement…
Phase: NA • Sponsor: University of Wisconsin, Madison • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Could eye pigment levels predict vision damage in severe nearsightedness?
Knowledge-focused CompletedThis study examined 39 people with severe nearsightedness to see if lower levels of a natural eye pigment (macular pigment) are linked to tiny cracks in the back of the eye called lacquer cracks. These cracks can lead to vision loss. The researchers measured the pigment's optical…
Phase: NA • Sponsor: Poitiers University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Scientists track night vision changes in macular degeneration over 5 years
Knowledge-focused CompletedThis study followed 57 people with age-related macular degeneration (AMD) for up to 5 years to see how their eyes adjust to darkness. Participants had yearly eye exams and dark adaptation tests, where they sat in a dark room and pressed a button when they saw a light. The goal wa…
Sponsor: National Eye Institute (NEI) • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Can your phone replace an eye exam? new study puts app to the test
Knowledge-focused CompletedThis study checked if a smartphone app called VisionApp can accurately measure vision problems like nearsightedness and presbyopia (age-related reading difficulty). Sixteen adults aged 40 and older used the app at home, and their results were compared to standard eye exams. The g…
Phase: NA • Sponsor: Indiana University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Frozen tumors, clearer vision? scientists dig into 20 years of eye records
Knowledge-focused CompletedThis study looks back at 20 years of medical records from 25 people who had a freezing treatment (cryotherapy) for retinal hemangioblastoma, a rare eye tumor often linked to von Hippel-Lindau disease. Researchers want to see how well the treatment controlled the tumors and affect…
Sponsor: National Eye Institute (NEI) • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
MRI scans reveal blood flow secrets in glaucoma eyes
Knowledge-focused CompletedThis study used MRI to measure blood flow in the eye's main artery in 20 adults with untreated glaucoma and compared it to healthy people. The goal was to understand how blood flow problems might contribute to glaucoma damage. Participants had one MRI scan, and no treatment was g…
Phase: NA • Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
Brain scans reveal hidden damage in glaucoma patients
Knowledge-focused CompletedThis study used high-powered 3-Tesla MRI to compare the visual pathways in the brains of 114 people with glaucoma and healthy volunteers. Researchers looked at the structure and volume of brain areas involved in vision to see if glaucoma causes damage beyond the eye. The goal was…
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
Sjögren's syndrome study digs deep into Mind-Body connection
Knowledge-focused CompletedThis study looked at 100 people with primary Sjögren's syndrome to understand how the disease affects their physical, emotional, and social well-being. Researchers used questionnaires and simple tests to measure symptoms like fatigue, pain, swallowing problems, and mood. A health…
Sponsor: Kahramanmaras Sutcu Imam University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
New syringe for eye disease injections passes usability test
Knowledge-focused CompletedThis study tested whether doctors could safely and correctly use a new prefilled syringe (SCD411) for eye injections. It included 33 adults with wet age-related macular degeneration, retinal vein occlusion, diabetic macular edema, or diabetic retinopathy. The main goal was to see…
Phase: PHASE2 • Sponsor: Sam Chun Dang Pharm. Co. Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
Light-Based brain cap could replace radiation scans for kids
Knowledge-focused CompletedThis study tested whether two light-based technologies, fNIRS and DCS, can safely measure brain activity in children with rare neurocognitive disorders like Niemann-Pick disease and Smith-Lemli-Opitz syndrome. 73 participants, including healthy volunteers, wore a cap with lights …
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:03 UTC
-
Are women with autoimmune diseases getting the gynecological care they need?
Knowledge-focused CompletedThis study examined whether women with autoimmune diseases or inflammatory rheumatism receive proper gynecological follow-up, including cervical cancer screening and contraception advice. Researchers surveyed 318 women with conditions like lupus, rheumatoid arthritis, and Sjögren…
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:03 UTC
-
New lens for cataracts: how happy are patients after surgery?
Knowledge-focused CompletedThis study looked at 307 cataract patients who received a special lens called TECNIS PC IOL to correct both cataracts and presbyopia (age-related blurry near vision). Researchers collected information from medical records and questionnaires to see how well patients saw, how satis…
Sponsor: Johnson & Johnson Surgical Vision, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:03 UTC
-
Special contact lenses may slow nearsightedness in kids
Knowledge-focused CompletedThis study followed 248 children with nearsightedness who wore soft bifocal contact lenses for two years and then switched to regular lenses for a third year. Researchers measured eye growth, light exposure, and pupil responses to understand why some children's nearsightedness ge…
Sponsor: Ohio State University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Artificial eye users may face hidden dry eye damage
Knowledge-focused CompletedThis study looked at 20 adults who wear an artificial eye to see if it causes more dry eye symptoms and damage to the tiny oil glands in the eyelids. Researchers compared the artificial eye side with the healthy eye side using special imaging and questionnaires. The goal was to u…
Sponsor: Instituto de Oftalmología Fundación Conde de Valenciana • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Filtering serum eye drops: does it remove key healing molecules?
Knowledge-focused CompletedThis study involved 10 adults with severe dry eye disease who did not respond to standard treatments. Researchers measured levels of growth factors and vitamins in autologous serum eye drops before and after filtration, to see if filtering reduces their concentration. The goal is…
Phase: NA • Sponsor: University Hospital, Limoges • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Eye disease biobank seeks clues to uveitis
Knowledge-focused CompletedThis study collected blood, saliva, and eye fluid samples from 343 people with uveitis, an inflammatory eye disease that can cause vision loss. Researchers aimed to learn which genes and other factors might lead to the disease and affect treatment response. Participants were foll…
Sponsor: National Eye Institute (NEI) • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Can a simple questionnaire on eye rubbing help fight a rare eye disease?
Knowledge-focused CompletedThis study tested a new questionnaire to better understand eye rubbing habits in people with or suspected keratoconus, a condition where the cornea thins and bulges. Researchers enrolled 292 participants to see if the questionnaire is reliable and useful. The goal is to improve h…
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Study reveals vaccine response in Immune-Compromised patients
Knowledge-focused CompletedThis study looked at how people with autoimmune diseases like multiple sclerosis or blistering skin conditions respond to COVID-19 vaccines while on B-cell depleting therapies. Researchers measured antibody levels and T-cell activity over time to understand vaccine effectiveness …
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC
-
New eye formula nails lens power in cataract study
Knowledge-focused CompletedThis study checked how accurate a new formula (Barrett TAL) is at picking the right lens power for cataract surgery. Over 500 people had their vision measured before and after surgery. The goal was to see if the formula helps more people get near-perfect vision without glasses af…
Sponsor: Shammas Eye Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC
-
New study reveals the hidden toll of nearsightedness on daily life
Knowledge-focused CompletedThis study looked at how nearsightedness (myopia) affects the quality of life of children and adults. Researchers surveyed parents of nearsighted children and adults with long-term complications from myopia. The goal was to understand the real-world impact of the condition, not t…
Sponsor: Santen SAS • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Divers' eye pressure spikes during breath-holds, study finds
Knowledge-focused CompletedThis study looked at how eye pressure changes when breath-hold divers hold their breath. Forty divers had their eye pressure, oxygen levels, heart rate, and blood pressure measured before, during, and after holding their breath. The goal was to understand these changes and how th…
Sponsor: University Hospital Olomouc • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Baby sucking study aims to improve feeding for fragile newborns
Knowledge-focused CompletedThis completed study looked at how 26 premature infants and babies with Pierre Robin sequence suck. The goal was to better understand their feeding challenges so doctors and families can offer better support. Researchers used a special device to measure sucking patterns, aiming t…
Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Scientists uncover immune cell clues in rare scleroderma
Knowledge-focused CompletedThis study looked at 235 people to understand how certain immune cells, called innate T cells, might be involved in systemic sclerosis (a rare disease that causes hardening of the skin and organs). Researchers compared patients with systemic sclerosis to those with other autoimmu…
Phase: NA • Sponsor: Poitiers University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Can a remote eye exam replace the Doctor's office for diabetic patients?
Knowledge-focused CompletedThis study looked at whether monitoring moderate diabetic retinopathy (an eye condition caused by diabetes) through tele-expertise (remote specialist review) works as well as the usual in-person eye doctor visits. Researchers followed 97 patients with diabetes and moderate retino…
Sponsor: Centre Hospitalier Sud Francilien • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
Gut clues could unlock Sjogren's mystery
Knowledge-focused CompletedThis study looked at whether immune cells from the intestine play a role in Sjogren's syndrome, an autoimmune disease that causes dry eyes and mouth. Researchers examined saliva gland samples from 57 adults suspected of having Sjogren's. The goal was to better understand the dise…
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
Can losing weight weaken your bones? new study investigates
Knowledge-focused CompletedThis pilot study looked at how weight loss affects bone density in overweight or obese men. 44 men either followed a reduced-calorie diet to lose weight or maintained their weight for 6 months. Researchers measured changes in bone density and quality to see if weight loss has any…
Phase: NA • Sponsor: Rutgers University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC
-
Glaucoma study reveals how quickly early cases worsen
Knowledge-focused CompletedThis study followed 326 people newly diagnosed with glaucoma or high eye pressure to see how many got worse over 2 to 4 years of standard monitoring in hospital eye clinics. Researchers measured the rate of disease progression and looked for factors that might predict worsening. …
Sponsor: University of Aberdeen • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC
-
8-Year eye study seeks clues to prevent blindness in seniors
Knowledge-focused CompletedThis study followed 516 older adults in France for 8 years to see how many develop age-related macular degeneration (AMD), a leading cause of blindness. Researchers used eye exams and imaging to track the disease and look for risk factors like genetics and lifestyle. The goal is …
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC
-
Arm placement may influence eye pressure during surgery
Knowledge-focused CompletedThis study looked at how the position of a patient's arms during spinal anesthesia affects pressure inside the eye. Sixty adults having hernia repair were randomly placed with arms at their sides or hands on their chest. Eye pressure was measured before and after anesthesia to se…
Phase: NA • Sponsor: Elazıg Fethi Sekin Sehir Hastanesi • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC
-
MS nerve damage unmasked: eye scans reveal hidden loss
Knowledge-focused CompletedThis study looked at how nerve cells in the eye are lost in people with multiple sclerosis (MS) even when there is no active inflammation. Researchers followed 64 adults with relapsing-remitting MS who were already part of a larger study. By using special eye scans over time, the…
Phase: NA • Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC
-
Which eye scanner is best for cataract surgery? new study puts two devices to the test
Knowledge-focused CompletedThis study compared two devices that measure the eye before cataract surgery to help pick the right lens implant. 144 Thai adults had both measurements taken on the same day. The goal was to see which device more accurately predicted the patient's vision one month after surgery.
Phase: NA • Sponsor: Walailak University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
Study reveals how eye damage tracks with vision decline in dry AMD
Knowledge-focused CompletedThis study examined how vision loss progresses in people with geographic atrophy, an advanced form of dry age-related macular degeneration. Researchers analyzed past medical records and eye images from 60 patients to see which retinal changes are linked to faster vision decline. …
Sponsor: IRCCS Ospedale San Raffaele • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
Better glasses for down syndrome? study tests eye dilation trick
Knowledge-focused CompletedThis study looked at whether using eye drops to dilate (widen) the pupils before measuring vision leads to better eyeglass prescriptions for people with Down syndrome. 42 participants had their vision tested with and without dilation. The goal was to see which method gives sharpe…
Phase: PHASE2 • Sponsor: Ohio State University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC
-
Scientists investigate immune cell role in rare IgG4 disease
Knowledge-focused CompletedThis study looked at a rare disease called IgG4-related disease, which causes swelling and scarring in organs. Researchers compared immune cells in the blood of 75 people: those with the disease, those with Sjogren syndrome, and healthy volunteers. The goal was to better understa…
Phase: NA • Sponsor: Assistance Publique Hopitaux De Marseille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC
-
Food safety training put to the test: do workers learn better habits?
Knowledge-focused CompletedThis study looked at whether a food safety training program helps food service employees improve their knowledge, attitudes, and practices around safe food handling. About 200 adult workers took part, and the training covered personal hygiene and safe food preparation. The goal w…
Phase: NA • Sponsor: Kayseri University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Eye imaging study aims to predict who will lose sight from AMD
Knowledge-focused CompletedThis completed study collected eye images from 1,000 people with intermediate age-related macular degeneration (AMD) to create a detailed database. Researchers will analyze these images to find signs that predict whether the disease will worsen to advanced stages. The goal is to …
Sponsor: Association for Innovation and Biomedical Research on Light and Image • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
New study reveals clues to survival after cardiac arrest
Knowledge-focused CompletedThis study looked back at the medical records of 168 adults who survived a cardiac arrest and were treated in the intensive care unit. Researchers wanted to find early signs that could predict which patients were more likely to die within 30 days or six months. By analyzing lab r…
Sponsor: Ahmet Düzgün • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Eye scans may predict vision loss in diabetes
Knowledge-focused CompletedThis study looked at 60 adults with type 2 diabetes and early diabetic eye disease. Researchers used a special eye scan (OCTA) to measure blood flow in the retina. The goal was to find which scan details best predict if the disease will get worse and threaten sight. No treatment …
Sponsor: Association for Innovation and Biomedical Research on Light and Image • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
New study tests best methods to prevent blindness in rural areas
Knowledge-focused CompletedThis study tested four different approaches to find and treat eye diseases like cataracts, glaucoma, and diabetic retinopathy in communities in Nepal. Over 87,000 people aged 50 and older took part. The goal was to see which method—comprehensive screening, cataract camps, communi…
Phase: NA • Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Eczema drug Tralokinumab's eye risks under the microscope
Knowledge-focused CompletedThis study looked at 100 adults with atopic dermatitis (eczema) who were prescribed tralokinumab. Researchers tracked how many developed eye problems like conjunctivitis within 4 months of starting the drug. The goal was to better understand these side effects in real-world use, …
Sponsor: Nantes University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
Pill or IV? small study tests safer sedation for Seniors' eye surgery
Knowledge-focused CompletedThis pilot study tested whether giving a sedative pill (alprazolam) before cataract surgery works as well as IV sedation (midazolam) in adults 65 and older. Twenty participants were randomly assigned to one of the two approaches, and researchers measured how well their thinking a…
Phase: PHASE4 • Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:25 UTC
-
Could steroid eye drops save premature Babies' sight?
Knowledge-focused CompletedThis study tested dexamethasone eye drops in 11 premature infants at risk of blindness from retinopathy of prematurity. Researchers measured how the drug enters the blood and saliva, and monitored for side effects. The goal was to gather safety and dosing information, not to prov…
Phase: PHASE1 • Sponsor: Region Skane • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:25 UTC
-
Eye surgery showdown: which cornea transplant is safer?
Knowledge-focused CompletedThis study compared two types of cornea transplant surgery (DSAEK and DMEK) for people with Fuchs' endothelial dystrophy, a condition that clouds the cornea. Researchers measured vision and tracked side effects like swelling and eye pressure in 112 participants. The goal was to f…
Phase: NA • Sponsor: University of Aarhus • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:25 UTC
-
Eye camera spots hidden inflammation in MS patients
Knowledge-focused CompletedThis study used a special eye camera (adaptive optics) to look at blood vessel inflammation in the retina of 50 people with multiple sclerosis (MS) and healthy volunteers. The goal was to see if this inflammation differs between MS types and could serve as an early marker of dise…
Phase: NA • Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
Where should you get cataract surgery? study compares costs
Knowledge-focused CompletedThis study looked at the costs of cataract surgery done in a doctor's office versus an ambulatory surgery center. Researchers analyzed data from 76 patients who had routine cataract surgery. The goal was to see which setting is more cost-effective.
Sponsor: Rush Eye Associates • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
Eye infection study: does early surgery save sight better than drugs?
Knowledge-focused CompletedThis study looked back at 170 adults with a serious eye infection called endophthalmitis to see if early surgery (within 48 hours) helps vision more than starting with medicine alone. Researchers compared how well people could see one month after treatment. The goal is to find ou…
Sponsor: University Hospital, Brest • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Brain surgery fluid strategy tested in 32 patients
Knowledge-focused CompletedThis study tested two different fluid management approaches during brain tumor removal surgery. 32 adults were monitored to see which method led to better recovery, measured by blood lactate levels. The goal was to find the best way to give fluids during surgery to improve patien…
Phase: NA • Sponsor: Cairo University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Eye flakes and wrist pain: surprising connection found?
Knowledge-focused CompletedThis study examined whether pseudoexfoliation syndrome (an eye condition) is related to carpal tunnel syndrome (a wrist nerve problem). Researchers measured blood markers in 159 adults aged 50-80. The goal was to see if these conditions share a common cause, not to test a treatme…
Sponsor: Ankara Training and Research Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC
-
Does donor diabetes impact corneal transplant outcomes?
Knowledge-focused CompletedThis completed study looked at whether diabetes in a cornea donor affects the success of a corneal transplant called DMEK. Over 1,000 participants received a cornea from either a donor with or without diabetes. Researchers tracked graft failure and cell loss for one year to see i…
Phase: NA • Sponsor: Case Western Reserve University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC
-
Eye muscle measurements may flag risky cataract surgeries
Knowledge-focused CompletedThis study looked at 30 men taking alpha-blocker drugs for urinary symptoms who were scheduled for cataract surgery. Researchers used a special eye scan to measure the thickness of iris muscles and pupil size. The goal was to see if these measurements could predict intraoperative…
Sponsor: University Hospital Olomouc • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
New lens shows promise for clearer vision after cataracts
Knowledge-focused CompletedThis completed study looked at how well people see and how satisfied they are after getting the TECNIS Odyssey lens in both eyes during cataract surgery. Forty patients aged 50 and older were checked at least three months after surgery. Researchers measured vision at different di…
Sponsor: Mann Eye Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
Eye injection burden varies by disease, study finds
Knowledge-focused CompletedThis study looked at how much of a burden patients feel from repeated anti-VEGF eye injections for three different eye diseases: wet age-related macular degeneration, retinal vein occlusion, and diabetic macular edema. Researchers surveyed 393 patients about their treatment burde…
Sponsor: Hospital Hietzing • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC
-
Hidden gut troubles in Sjögren's patients revealed
Knowledge-focused CompletedThis study looked at how often people with primary Sjögren's syndrome have digestive issues. Researchers asked 151 patients about 10 different digestive symptoms using a simple questionnaire. The goal was to understand which symptoms are most common and how they relate to how lon…
Phase: NA • Sponsor: University Hospital, Limoges • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC
-
Can a simple supplement help aging eyes? stanford investigates
Knowledge-focused CompletedThis early-phase study at Stanford looked at how a nutritional supplement called alpha-ketoglutarate is absorbed into the eyes when taken orally. Seventeen adults with age-related eye diseases participated. The main goal was to measure changes in the supplement's level in eye flu…
Phase: EARLY_PHASE1 • Sponsor: Stanford University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC
-
Eye-Opening study: do two Pre-Cataract scanners agree?
Knowledge-focused CompletedThis study checked how well two different devices (OA-2000 and Pentacam AXL) agree when measuring the eye before cataract surgery. 94 cataract patients had their eyes measured once with each device. The goal was to see if the devices give the same numbers for lens power and eye s…
Sponsor: Burapha University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:02 UTC
-
Does the type of eye tamponade affect retinal shift after detachment repair?
Knowledge-focused CompletedThis study looked at 78 people in Pakistan who had surgery for a detached retina. Doctors compared two types of fillers used inside the eye after surgery—gas or silicone oil—to see if one caused more shifting of the retina afterward. The goal was to learn how the choice of filler…
Phase: NA • Sponsor: Wardah • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:02 UTC
-
Scientists decode DNA of rare eye tumors to track Cancer's moves
Knowledge-focused CompletedThis study looked at the DNA changes (mutations) in eye cancers called ocular melanoma. Researchers analyzed tumor samples from 58 patients to understand how these cancers develop and spread. The goal was to identify key mutations that could lead to better treatments in the futur…
Sponsor: The Wellcome Sanger Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:02 UTC
-
Which cataract surgery device works better? new study compares two top systems
Knowledge-focused CompletedThis completed study looked at 80 people having routine cataract surgery in both eyes. Researchers compared two different phacoemulsification devices (Quatera 700 and Centurion) to see how they affected corneal thickness and how long it took to remove the lens. The goal was to ga…
Phase: NA • Sponsor: Carolina Eyecare Physicians, LLC • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
New eye scanner put to the test in small study
Knowledge-focused CompletedThis study tested a new device called the EYESTAR 900, which uses light to take detailed measurements of the eye's shape. 29 people with healthy eyes, corneal scarring, or irregular astigmatism took part. The goal was to see how well the new scanner measures eye geometry compared…
Phase: NA • Sponsor: Haag-Streit AG • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
Eye study tracks early AMD changes to spot future risks
Knowledge-focused CompletedThis completed study followed 26 adults aged 55 and older with early age-related macular degeneration (AMD) or healthy eyes for up to 5 years. Researchers used eye exams, imaging, and vision tests to track changes in the retina and visual function. The goal was to better understa…
Sponsor: National Eye Institute (NEI) • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
COVID-19's hidden toll on autoimmune patients revealed
Knowledge-focused CompletedThis study followed 293 people with autoimmune diseases and healthy volunteers to see how COVID-19 infection or vaccination affects their immune system, inflammation, and blood vessels. Participants were grouped based on their COVID-19 history and had up to 5 visits over 12-18 mo…
Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
Simple eye test could predict nerve damage in dry eye sufferers
Knowledge-focused CompletedThis completed study looked at 31 people with dry eye to see if measuring corneal sensitivity (how well the eye feels touch) can detect early-stage neurotrophic keratopathy, a condition where the cornea loses sensation. Researchers aimed to find out which dry eye patients might l…
Phase: NA • Sponsor: Research Insight LLC • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
Immune clues in rare lung disease explored
Knowledge-focused CompletedThis completed study looked at how the immune system might affect the outlook for people with pulmonary arterial hypertension (PAH). Researchers took blood and skin samples from 629 participants with different types of PAH to search for specific antibodies. The goal was to better…
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
How many autoimmune patients try alternative therapies? new study counts
Knowledge-focused CompletedThis completed study surveyed 121 adults with autoimmune diseases like lupus, Sjögren's syndrome, or scleroderma. Participants filled out a questionnaire about their use of alternative medicines. The goal was to find out how common these practices are in this patient group.
Sponsor: University Hospital, Limoges • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
Scientists probe eye fluid to uncover why some macular degeneration patients Don't get better
Knowledge-focused CompletedThis study looked at proteins in the eye fluid of 100 people with wet age-related macular degeneration (AMD). The goal was to measure certain growth factors that might explain why about 37% of patients do not respond well to standard anti-VEGF injections. Researchers collected a …
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
LASIK satisfaction survey: 300 patients weigh in on vision and dry eye
Knowledge-focused CompletedThis completed study looked at how satisfied 300 people were with their vision at least one year after having Wavelight LASIK surgery for nearsightedness (myopia). Researchers also checked for dry eye symptoms using standard questionnaires. The goal was to understand real-world p…
Sponsor: OVO LASIK + Lens • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
AI predicts eye surgery outcomes better than standard methods?
Knowledge-focused CompletedThis study looked at data from 1100 people who had SMILE laser eye surgery to fix nearsightedness. Researchers used a computer model to predict how well patients would see one year after surgery. The goal was to see if the model could give more accurate results than the usual pla…
Sponsor: Tongji University • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
Eye scanner showdown: can new tech reduce need for ultrasound in dense cataracts?
Knowledge-focused CompletedThis study looked at two different eye scanners (ARGOS and IOLMaster 700) used to measure the length of the eye in people with dense cataracts. Researchers wanted to see if the newer scanner could get accurate measurements more often, potentially reducing the need for a more invo…
Sponsor: Berkeley Eye Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
Gum inflammation linked to eye disease in small study
Knowledge-focused CompletedThis study compared gum health and levels of inflammatory substances in the mouth and blood of 25 people with non-infectious uveitis (an eye inflammation) and 27 healthy individuals. Researchers measured gum pocket depth, bleeding, and cytokines like TNF-α and IL-10. The goal was…
Sponsor: Selcuk University • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
Apple watches reveal surprising effects of air purifiers on your body
Knowledge-focused CompletedThis study tested whether using an indoor air purifier changes health measures like heart rate, sleep, and oxygen levels. 42 healthy adults wore Apple Watches while using a real or fake (sham) air purifier at home. The goal was to see if cleaner air makes a short-term difference …
Phase: NA • Sponsor: New York University Abu Dhabi • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
Nearsighted patients studied for retinal detachment risk after cataract surgery
Knowledge-focused CompletedThis study followed 609 nearsighted adults who had lens surgery to see if a natural eye change called posterior vitreous detachment (PVD) affects their risk of retinal detachment. Participants were grouped by whether they had PVD before surgery or not, and were monitored for up t…
Sponsor: Prim. Prof. Dr. Oliver Findl, MBA • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
Eye rubbing habits linked to uneven keratoconus severity
Knowledge-focused CompletedThis study looked at 154 people with keratoconus, a condition that thins and bulges the cornea, to understand why it is often worse in one eye than the other. Researchers compared those with uneven severity to those with similar severity in both eyes, focusing on eye rubbing habi…
Sponsor: Centre Hospitalier Régional Metz-Thionville • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
Navigating blindness: simple program aims to save sight in diabetics
Knowledge-focused CompletedThis pilot study tested whether a patient navigator—a person who helps coordinate medical care—could increase eye exam rates in 35 adults with diabetes who were at high risk for blindness. Participants met with a navigator quarterly to overcome barriers to care. The study measure…
Phase: NA • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
Tiny study tests Super-Camera to spot retina damage early
Knowledge-focused CompletedThis study tested a new type of camera that can see individual cells in the retina, which standard clinical cameras cannot do. Five people with retinal disease (inherited degeneration or toxicity) had their eyes scanned with the device. The goal was to compare image quality and o…
Phase: NA • Sponsor: Indiana University • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
Breath test could replace needles for monitoring anesthesia in kids
Knowledge-focused CompletedThis study looked at whether the amount of propofol (anesthesia medicine) in a child's breath matches the amount in their blood during eye surgery. 32 children took part, and the researchers compared breath measurements with blood samples and brain activity. The goal was to see i…
Phase: NA • Sponsor: Oslo University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
New digital tool could make eye scar assessment more accurate
Knowledge-focused CompletedThis study tested a digital color scale to objectively measure scarring of the eye's surface in people with recurrent pterygium, a growth that can come back after surgery. Researchers took photos of 25 patients' eyes and used software to analyze the scar tissue. The goal was to s…
Sponsor: Instituto de Oftalmología Fundación Conde de Valenciana • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
Melanoma Drug's eye impact revealed in new study
Knowledge-focused CompletedThis study looked at 14 adults with melanoma who were taking a combination of BRAF and MEK inhibitor drugs. The goal was to understand how these drugs can affect the retina, the light-sensitive part of the eye. Researchers used eye exams and special imaging to track changes over …
Sponsor: Institute of Oncology Ljubljana • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC
-
Scientists probe eye fluid secrets to personalize glaucoma treatment
Knowledge-focused CompletedThis study looked at how the eye produces and drains fluid to understand why glaucoma medications lower eye pressure more in some people than others. Researchers measured eye fluid production, drainage, and pressure in 59 adults with glaucoma or high eye pressure before and after…
Phase: PHASE4 • Sponsor: Ohio State University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC
-
New study tracks daily life impact of rare eye disease
Knowledge-focused CompletedThis study looked at 44 people with a rare inherited eye condition called Leber Hereditary Optic Neuropathy (LHON) that causes vision loss. Researchers reviewed medical records and asked participants about their vision, health, and quality of life. The goal was to better understa…
Sponsor: GenSight Biologics • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC
-
Small study tracks rare disease to pave way for future treatments
Knowledge-focused CompletedThis study followed 10 people with late onset Tay-Sachs disease to see how their symptoms and body chemistry changed over six months. Researchers measured balance, coordination, and brain chemicals. The goal was to gather information that will help design better clinical trials f…
Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC
-
Massive MPS i registry sheds light on rare disease
Knowledge-focused CompletedThis registry tracked over 1,400 people with MPS I, a rare genetic disorder, to better understand how the disease progresses and how treatments like enzyme replacement therapy work over time. It did not test a new drug but collected real-world data to help doctors improve patient…
Sponsor: Genzyme, a Sanofi Company • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC
-
Eye tissue thickness measured in macular disease patients and healthy adults
Knowledge-focused CompletedThis study measured the thickness of the conjunctiva and Tenon's capsule (outer eye layers) in 736 people with neovascular age-related macular degeneration (nAMD) or diabetic macular edema (DME), and in healthy volunteers of similar age. Researchers used a special eye scanner (SD…
Sponsor: Hoffmann-La Roche • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC
-
Blood tests may reveal hidden eye damage in diabetes
Knowledge-focused CompletedThis study measured three substances in the blood (endocan, alarin, and galanin-like peptide) in people with and without diabetic retinopathy, an eye complication of diabetes. Researchers compared these levels across different stages of the disease and looked at how they relate t…
Phase: NA • Sponsor: Elazıg Fethi Sekin Sehir Hastanesi • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC
-
Eye measurement showdown: which device is best for lens surgery?
Knowledge-focused CompletedThis study compared two different optical devices that measure the eye before cataract or presbyopia surgery. 133 patients had their eyes measured with both devices to see if the measurements matched. The goal was to help doctors choose the best tool for planning lens implants.
Sponsor: Democritus University of Thrace • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC
-
Cataract lens study checks vision quality after surgery
Knowledge-focused CompletedThis study looked at how well the Clareon Vivity and Vivity Toric intraocular lenses work in people who already had cataract surgery. Researchers measured vision at different distances in 155 participants. The goal was to confirm the lenses perform as expected and support their u…
Phase: NA • Sponsor: Alcon Research • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC
-
New device aims to sharpen cataract surgery results for prior laser patients
Knowledge-focused CompletedThis study tested a device called IOLMASTER 700 TK to see if it can more accurately measure the eye's curvature in people who had laser vision correction and now need cataract surgery. Researchers compared four different lens calculation methods in 155 adults. The goal was to imp…
Sponsor: Advanced Vision Care • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC
-
Blood test uncovers rare diseases in patients with mysterious enlarged spleen
Knowledge-focused CompletedThis study looked for two rare genetic diseases, Gaucher disease and acid sphingomyelinase deficiency (ASMD), in 122 adults with an unexplained enlarged spleen or who had their spleen removed for unknown reasons. Researchers used a simple blood spot test to check enzyme activity …
Sponsor: Fundación Española de Hematología y Hemoterapía • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC
-
New registry aims to improve corneal transplants with AI
Knowledge-focused CompletedThis study created a nationwide registry to track long-term results of corneal surgeries and diseases. Researchers collected images and data from 19 participants to help understand what makes corneal transplants successful. The goal is to use this information to develop AI that c…
Sponsor: Nitin Vaswani • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC
-
PCOS drugs may change your eyes – new study reveals
Knowledge-focused CompletedThis study examined how common PCOS treatments (birth control pills and clomiphene citrate) affect the eyes. Researchers measured dry eye signs and retinal blood vessels in 60 women with PCOS and compared them to 30 healthy women. The goal was to see if these treatments cause cha…
Sponsor: Cairo University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC
-
Could an antioxidant help gaucher disease? new study investigates
Knowledge-focused CompletedThis study measured levels of brain chemicals related to oxidative stress and inflammation in people with type 1 Gaucher disease and healthy volunteers. Researchers gave 33 participants with Gaucher disease the antioxidant N-acetylcysteine (NAC) for about 90 days to see if it cha…
Phase: PHASE2 • Sponsor: University of Minnesota • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
New eye scanner aims to sharpen vision after cataract surgery
Knowledge-focused CompletedThis study looked at how accurately the Alcon Vision Suite with Argos biometer predicts the right lens power for people having cataract surgery. 106 adults aged 45 and older who chose either Clareon PanOptix or AcrySof Vivity lenses took part. The goal was to see if the device he…
Sponsor: Valley Laser Eye Centre • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
Eye fluid analysis may predict Post-Surgery dry eye
Knowledge-focused CompletedThis study analyzed tear and eye fluid samples from 100 cataract surgery patients to find biomarkers that could predict dry eye disease after surgery. Researchers used advanced chemical analysis to look for clues in the eye's surface cells and inner fluid. The goal is to better u…
Phase: NA • Sponsor: University Hospital, Tours • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC
-
Eye bleeding study seeks best fix for macular degeneration patients
Knowledge-focused CompletedThis study looked at 91 people with a type of bleeding in the eye caused by age-related macular degeneration (AMD). It compared two treatments: surgery followed by anti-VEGF injections, or a gas injection followed by anti-VEGF injections. The goal was to see which approach helps …
Phase: NA • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC
-
Massive french study reveals infection rates after common eye injections
Knowledge-focused CompletedThis study looked at 360,000 French patients who received eye injections for conditions like age-related macular degeneration. The goal was to find out how often a serious eye infection called endophthalmitis happens within 28 days after the injection. Researchers analyzed data f…
Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
New study peers into the Eye's recovery after retinal detachment
Knowledge-focused CompletedThis study looked at 202 people who had surgery for retinal detachment, a condition where the light-sensitive layer at the back of the eye pulls away. Researchers used high-resolution eye scans and vision tests to see how the eye heals over a year. The goal was to better understa…
Phase: NA • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC